<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8037269</article-id><article-id pub-id-type="pmid">33804820</article-id><article-id pub-id-type="doi">10.3390/ijms22073289</article-id><article-id pub-id-type="publisher-id">ijms-22-03289</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Beneficial Impacts of Alpha-Eleostearic Acid from Wild Bitter Melon and Curcumin on Promotion of CDGSH Iron-Sulfur Domain 2: Therapeutic Roles in CNS Injuries and Diseases</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8311-2902</contrib-id><name><surname>Kung</surname><given-names>Woon-Man</given-names></name><xref ref-type="aff" rid="af1-ijms-22-03289">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9798-8160</contrib-id><name><surname>Lin</surname><given-names>Muh-Shi</given-names></name><xref ref-type="aff" rid="af2-ijms-22-03289">2</xref><xref ref-type="aff" rid="af3-ijms-22-03289">3</xref><xref ref-type="aff" rid="af4-ijms-22-03289">4</xref><xref ref-type="aff" rid="af5-ijms-22-03289">5</xref><xref rid="c1-ijms-22-03289" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Brunetti</surname><given-names>Luigi</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-ijms-22-03289"><label>1</label>Department of Exercise and Health Promotion, College of Kinesiology and Health, Chinese Culture University, Taipei 11114, Taiwan; <email>nskungwm@yahoo.com.tw</email></aff><aff id="af2-ijms-22-03289"><label>2</label>Division of Neurosurgery, Department of Surgery, Kuang Tien General Hospital, Taichung 43303, Taiwan</aff><aff id="af3-ijms-22-03289"><label>3</label>Department of Biotechnology and Animal Science, College of Bioresources, National Ilan University, Yilan 26047, Taiwan</aff><aff id="af4-ijms-22-03289"><label>4</label>Department of Biotechnology, College of Medical and Health Care, Hung Kuang University, Taichung 43302, Taiwan</aff><aff id="af5-ijms-22-03289"><label>5</label>Department of Health Business Administration, College of Medical and Health Care, Hung Kuang University, Taichung 43302, Taiwan</aff><author-notes><corresp id="c1-ijms-22-03289"><label>*</label>Correspondence: <email>neurosurgery2005@yahoo.com.tw</email>; Tel.: +886-4-2665-1900</corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>3</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2021</year></pub-date><volume>22</volume><issue>7</issue><elocation-id>3289</elocation-id><history><date date-type="received"><day>06</day><month>3</month><year>2021</year></date><date date-type="accepted"><day>21</day><month>3</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 by the authors.</copyright-statement><copyright-year>2021</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="pmc" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Neuroinflammation and abnormal mitochondrial function are related to the cause of aging, neurodegeneration, and neurotrauma. The activation of nuclear factor &#x003ba;B (NF-&#x003ba;B), exaggerating these two pathologies, underlies the pathogenesis for the aforementioned injuries and diseases in the central nervous system (CNS). CDGSH iron-sulfur domain 2 (CISD2) belongs to the human NEET protein family with the [2Fe-2S] cluster. CISD2 has been verified as an NF&#x003ba;B antagonist through the association with peroxisome proliferator-activated receptor-&#x003b2; (PPAR-&#x003b2;). This protective protein can be attenuated under circumstances of CNS injuries and diseases, thereby causing NF&#x003ba;B activation and exaggerating NF&#x003ba;B-provoked neuroinflammation and abnormal mitochondrial function. Consequently, CISD2-elevating plans of action provide pathways in the management of various disease categories. Various bioactive molecules derived from plants exert protective anti-oxidative and anti-inflammatory effects and serve as natural antioxidants, such as conjugated fatty acids and phenolic compounds. Herein, we have summarized pharmacological characters of the two phytochemicals, namely, alpha-eleostearic acid (&#x003b1;-ESA), an isomer of conjugated linolenic acids derived from wild bitter melon <italic>(Momordica charantia</italic> L. <italic>var. abbreviata Ser.)</italic>, and curcumin, a polyphenol derived from rhizomes of <italic>Curcuma longa</italic> L. In this review, the unique function of the CISD2-elevating effect of &#x003b1;-ESA and curcumin are particularly emphasized, and these natural compounds are expected to serve as a potential therapeutic target for CNS injuries and diseases.</p></abstract><kwd-group><kwd>alpha-eleostearic acid</kwd><kwd>curcumin</kwd><kwd>aging</kwd><kwd>neurodegenerative disease</kwd><kwd>neurotrauma</kwd><kwd>CISD2</kwd><kwd>neuroinflammation</kwd><kwd>mitochondrial dysfunction</kwd><kwd>NF&#x003ba;B</kwd></kwd-group></article-meta></front><body><sec id="sec1-ijms-22-03289"><title>1. Preface</title><p>Neuroinflammation is critically involved in the pathophysiology of acute injuries and diseases (including aging and neurodegeneration) in the central nervous system (CNS) [<xref rid="B1-ijms-22-03289" ref-type="bibr">1</xref>,<xref rid="B2-ijms-22-03289" ref-type="bibr">2</xref>,<xref rid="B3-ijms-22-03289" ref-type="bibr">3</xref>,<xref rid="B4-ijms-22-03289" ref-type="bibr">4</xref>]. Profound inflammatory responses are characterized by the activation of glial cells, which are primary innate immune cells of the CNS. Neuroinflammation can induce mitochondrial dysfunction. The main feature is that these reactive glial cells produce nitric oxide (NO) as well as reactive oxygen species (ROS) [<xref rid="B5-ijms-22-03289" ref-type="bibr">5</xref>]. Both mutually influencing pathogeneses, inflammation, mitochondrial dysfunction, and eventually neuronal function of the CNS [<xref rid="B6-ijms-22-03289" ref-type="bibr">6</xref>,<xref rid="B7-ijms-22-03289" ref-type="bibr">7</xref>].</p><p>Nuclear factor kappa-light-chain-enhancer of activated B cells (NF&#x003ba;B) has been shown to involve in inflammation and mitochondrial dysfunction [<xref rid="B8-ijms-22-03289" ref-type="bibr">8</xref>,<xref rid="B9-ijms-22-03289" ref-type="bibr">9</xref>]. NF&#x003ba;B activation can be inhibited by a distinctive zinc finger in addition to the iron-sulfur protein, CDGSH iron-sulfur domain 2 (CISD2) [<xref rid="B10-ijms-22-03289" ref-type="bibr">10</xref>]. The preventive effect of CISD2 in opposition to inflammation, and abnormal mitochondrial function supports its role to act as a therapeutic target for CNS injuries and diseases.</p><p>CISD2 expression level is decreased during CNS injuries and diseases [<xref rid="B10-ijms-22-03289" ref-type="bibr">10</xref>,<xref rid="B11-ijms-22-03289" ref-type="bibr">11</xref>,<xref rid="B12-ijms-22-03289" ref-type="bibr">12</xref>,<xref rid="B13-ijms-22-03289" ref-type="bibr">13</xref>]. As a controller of NF&#x003ba;B activation, CISD2 attenuation leads to an exaggerated NF&#x003ba;B activation. This review has focused on the neuromodulatory effects of phytochemicals, such as alpha-eleostearic acid (&#x003b1;-ESA) from <italic>Momordica charantia</italic> L. <italic>var. abbreviata Ser.</italic> (Cucurbitaceae) (commonly named as wild bitter melon, WBM) [<xref rid="B10-ijms-22-03289" ref-type="bibr">10</xref>], and curcumin from <italic>Curcuma longa</italic> L. (Zingiberaceae) [<xref rid="B12-ijms-22-03289" ref-type="bibr">12</xref>,<xref rid="B13-ijms-22-03289" ref-type="bibr">13</xref>], along with the emphasis of CISD2-elevating effects of these natural compounds. Natural medicine beneficial to CNS pathology-NF&#x003ba;B-CISD2 axis (<xref ref-type="fig" rid="ijms-22-03289-f001">Figure 1</xref>) can be recommended to treat CNS injuries and diseases.</p></sec><sec id="sec2-ijms-22-03289"><title>2. Innate Immune Cells in the CNS&#x02014;Microglia and Astrocytes</title><p>In general, microglia and astrocytes are resident glial cells in the CNS, and these two groups of cells can be activated in response to CNS injuries and diseases, consequently causing local inflammatory response, i.e., neuroinflammation [<xref rid="B14-ijms-22-03289" ref-type="bibr">14</xref>]. As with peripheral macrophages, microglia are embryologically derived from myeloid progenitors, whereas astrocytes are derived from neuroepithelial precursors [<xref rid="B15-ijms-22-03289" ref-type="bibr">15</xref>].</p><p>To maintain CNS homeostasis, microglia and astrocytes provide support and supply nutrition for neurons. Microglia provide neurotrophic support for neurons and mainly mediate immune responses to stabilize the CNS [<xref rid="B16-ijms-22-03289" ref-type="bibr">16</xref>]. Astrocyte-mediated neuroprotection has been proposed to be due to the limitation of neuronal death from excitotoxins and oxidants [<xref rid="B17-ijms-22-03289" ref-type="bibr">17</xref>], maintenance energy metabolism [<xref rid="B18-ijms-22-03289" ref-type="bibr">18</xref>], and the regulation of osmolarity for volume control [<xref rid="B19-ijms-22-03289" ref-type="bibr">19</xref>]. Under environmental insults in the CNS, beneficial phenotypes (anti-inflammation) of M2 microglia and A2 astrocytes can be excessively stimulated and potentially switched to detrimental phenotypes (pro-inflammation) (M1 or A1, respectively) [<xref rid="B20-ijms-22-03289" ref-type="bibr">20</xref>].</p></sec><sec id="sec3-ijms-22-03289"><title>3. Diverse Causes of Glial Activation in CNS Injuries and Diseases </title><p>Glial cells can be activated to undergo neuroinflammation as a consequence of various factors in CNS injuries and diseases.</p><sec id="sec3dot1-ijms-22-03289"><title>3.1. Aging Process</title><p>Aging is widely defined as a decline of physiological integrity and gradual impairment of physiological functions over time, and it remains a major risk factor for neurodegenerative diseases [<xref rid="B21-ijms-22-03289" ref-type="bibr">21</xref>,<xref rid="B22-ijms-22-03289" ref-type="bibr">22</xref>]. Aging in the CNS has been due to cellular senescence and dysfunctional microglia. Microglial dysfunction results in resistance to immune adaptive regulation and the up-regulation of inflammatory genes. Eventually, the proposed senescent [<xref rid="B23-ijms-22-03289" ref-type="bibr">23</xref>,<xref rid="B24-ijms-22-03289" ref-type="bibr">24</xref>] or dysfunctional glia produce a number of proinflammatory cytokines [<xref rid="B25-ijms-22-03289" ref-type="bibr">25</xref>,<xref rid="B26-ijms-22-03289" ref-type="bibr">26</xref>].</p></sec><sec id="sec3dot2-ijms-22-03289"><title>3.2. Neurodegenerative Diseases</title><p>Abnormal changes in the conformation of proteins, caused by environmental or genetic factors, lead to an aggregation of intracellular and extracellular proteins, thereby promoting neurodegenerative diseases [<xref rid="B27-ijms-22-03289" ref-type="bibr">27</xref>]. These abnormally folded/aggregated proteins implicated in neurodegenerative diseases are commonly known as: hyperphosphorylated tau, A&#x003b2;-peptide (for AD), &#x003b1;-synuclein (for PD), huntingtin (for Huntington disease), and prion (for prion diseases) [<xref rid="B28-ijms-22-03289" ref-type="bibr">28</xref>]. </p></sec><sec id="sec3dot3-ijms-22-03289"><title>3.3. Traumatic CNS Injuries</title><p>The brain and spinal cord can be damaged due to mechanical injuries, i.e., traumatic brain injury (TBI) and spinal cord injury (SCI). Primary trauma leads to structural destruction of vital organs, including cell membrane disruption, myelin and axon destruction, as well as neurovascular injury, which further triggers secondary injuries [<xref rid="B29-ijms-22-03289" ref-type="bibr">29</xref>]. Specifically, the activation of astrocytes and microglia in the neuroinflammation process involves a complex mechanism of secondary damage to the CNS [<xref rid="B30-ijms-22-03289" ref-type="bibr">30</xref>,<xref rid="B31-ijms-22-03289" ref-type="bibr">31</xref>]. In a mouse model of TBI, damage-triggered changes in astrocyte morphology have been shown to be accompanied by alternative localization and aggregation of &#x003b3;-synuclein, indicating potential neurodegenerative changes following CNS injuries [<xref rid="B32-ijms-22-03289" ref-type="bibr">32</xref>].</p></sec></sec><sec id="sec4-ijms-22-03289"><title>4. NF&#x003ba;B-Driven Neuroinflammation and Mitochondrial Dysfunction Implicated in CNS Injuries and Diseases</title><p>Under environmental stimuli in CNS, the aggregation of pattern recognition receptors (PRRs), including damage-associated molecular patterns (DAMPs) or pathogen-associated molecular patterns, activates M1 phase microglia and A1 phase astrocytes [<xref rid="B33-ijms-22-03289" ref-type="bibr">33</xref>], which in turn enhance neuroinflammation [<xref rid="B34-ijms-22-03289" ref-type="bibr">34</xref>]. Pathological mechanisms of glia-mediated neuroinflammation induce the production of several neurotoxic proinflammatory mediators, nitrogen species, and reactive oxygen species (ROS) [<xref rid="B35-ijms-22-03289" ref-type="bibr">35</xref>].</p><p>Mitochondrial functions such as mitochondrial dynamics, mitochondrial membrane permeabilization, and oxidative phosphorylation can be impaired under the circumstances of neuroinflammation [<xref rid="B36-ijms-22-03289" ref-type="bibr">36</xref>,<xref rid="B37-ijms-22-03289" ref-type="bibr">37</xref>]. These mitochondrial-derived DAMPs, mitochondrial debris, mitochondrial DNA, and cardiolipin trigger the excitation of NACHT, LRR, PYD domains-containing protein 3 (NLRP3) inflammasomes [<xref rid="B38-ijms-22-03289" ref-type="bibr">38</xref>], pro-caspase-1 activation, and production of proinflammatory mediators [<xref rid="B39-ijms-22-03289" ref-type="bibr">39</xref>]. This so-called vicious cascade induces the release of even more mitochondrial DAMPs, enhancing further inflammasome activation and more extensive glial neuroinflammation [<xref rid="B40-ijms-22-03289" ref-type="bibr">40</xref>].</p><p>As a critical transcription factor, NF&#x003ba;B can modulate the transcription of genes in innate and adaptive immunity, proinflammation, cell proliferation, and cellular apoptosis [<xref rid="B41-ijms-22-03289" ref-type="bibr">41</xref>]. Neuroinflammation [<xref rid="B42-ijms-22-03289" ref-type="bibr">42</xref>,<xref rid="B43-ijms-22-03289" ref-type="bibr">43</xref>] and mitochondrial dysfunction [<xref rid="B44-ijms-22-03289" ref-type="bibr">44</xref>] are both essential main pathogeneses involved in CNS injuries and diseases, and are provoked by NF&#x003ba;B. Specifically, detrimental insults in the CNS can turn on the I&#x003ba;B kinase (IKK) complex, causing phosphorylation and degradation of inhibitor of &#x003ba;B (I&#x003ba;B). I&#x003ba;B degradation leads to the unmasking of the nuclear localization signal (NLS) in p65/p50 or p50/c-Rel dimers, nuclear translocation of NF&#x003ba;B from cytoplasm, and proinflammation [<xref rid="B41-ijms-22-03289" ref-type="bibr">41</xref>]. Furthermore, in mitochondria, NF&#x003ba;B has been shown to regulate mitochondrial function [<xref rid="B9-ijms-22-03289" ref-type="bibr">9</xref>], including mitochondrial dynamics, activities of respiratory complexes for electron transport chain, and apoptosis [<xref rid="B9-ijms-22-03289" ref-type="bibr">9</xref>]. NF&#x003ba;B has been indicated to regulate the activities of NLRP3 inflammasomes [<xref rid="B45-ijms-22-03289" ref-type="bibr">45</xref>]. </p><p>To summarize, neuroinflammation and mitochondrial dysfunction underlie the pathological mechanisms of CNS injuries and diseases. Hence, treatment strategies against the two NF&#x003ba;B-provoked pathologies could be potentially beneficial.</p></sec><sec id="sec5-ijms-22-03289"><title>5. CISD2 as a Promising NF&#x003ba;B Antagonist</title><p>Our research team has demonstrated that CISD2 can block the stimulation of NF&#x003ba;B. Augmented DNA binding activity of the NF&#x003ba;B p65 subunit and nuclear translocation of NF&#x003ba;B p65 were verified in siCISD2-transfected EOC microglia (microglial cell lines) [<xref rid="B46-ijms-22-03289" ref-type="bibr">46</xref>]. CISD2 slows down NF&#x003ba;B signaling by acting upstream of peroxisome proliferator-activated receptor (PPAR)-&#x003b2; [<xref rid="B10-ijms-22-03289" ref-type="bibr">10</xref>]. PPAR-&#x003b2; has been shown to prevent I&#x003ba;B degradation and subsequent NF&#x003ba;B activation [<xref rid="B47-ijms-22-03289" ref-type="bibr">47</xref>,<xref rid="B48-ijms-22-03289" ref-type="bibr">48</xref>].</p><p>As an NF&#x003ba;B antagonist, the protective effects of CISD2 have been illustrated to exert anti-inflammatory and protective effects against abnormal mitochondrial function. </p><sec id="sec5dot1-ijms-22-03289"><title>5.1. Anti-Inflammation</title><sec id="sec5dot1dot1-ijms-22-03289"><title>5.1.1. In Vitro Neural Cell Model of Aging</title><p>Astrocytes from long-term cultures (35 days in vitro, <italic>DIV</italic>) presented a decrease in CISD2 expression along with higher expression of iNOS and normal T cells expressed and secreted (RANTES), when compared to the 7 <italic>DIV</italic> cells [<xref rid="B13-ijms-22-03289" ref-type="bibr">13</xref>]. </p></sec><sec id="sec5dot1dot2-ijms-22-03289"><title>5.1.2. In Vitro CISD2 Knockdown Model</title><p>Proinflammatory responses are demonstrated by the expressive levels of iNOS and RANTES in siCISD2-transfected neuron-like cells, SH-SY5Y [<xref rid="B12-ijms-22-03289" ref-type="bibr">12</xref>,<xref rid="B13-ijms-22-03289" ref-type="bibr">13</xref>]. Augmented inflammatory reactions are revealed by an increased M1 microglia polarization (increased expression of transforming necrosis factor-&#x003b1;, IL-1&#x003b2;, iNOS, and COX2), and decreased M2 microglia phenotype (decreased expression of Arg-1, Ym1, and IL-10) in siCISD2-transfected EOC microglial cells [<xref rid="B46-ijms-22-03289" ref-type="bibr">46</xref>].</p></sec></sec><sec id="sec5dot2-ijms-22-03289"><title>5.2. Protection against Mitochondrial Dysfunction</title><sec id="sec5dot2dot1-ijms-22-03289"><title>In Vitro CISD2 Knockdown Model</title><p>Profound mitochondrial dysfunction is detected in the CISD2 knockdown model using siCISD2 in SH-SY5Y neural cells. Attenuated mitochondrial membrane potential DeltaPsi (m), elevated ROS production, enhanced cellular apoptosis, and impaired cell survival are found in this model [<xref rid="B13-ijms-22-03289" ref-type="bibr">13</xref>].</p><p>As mentioned before, through the inhibition of NF&#x003ba;B, NF&#x003ba;B-driven NLRP3 inflammasomes, and subsequent inflammasome-mediated inflammation, CISD2 can be considered a promising target to treat inflammation and abnormal mitochondrial function.</p></sec></sec></sec><sec id="sec6-ijms-22-03289"><title>6. NEET Protein Family and Classification</title><p>In the family of NEET proteins, this unique amino acid sequence, Asparagine-Glutamate-Glutamate-Threonine, habitually occurs in the carboxyl end of each family member [<xref rid="B49-ijms-22-03289" ref-type="bibr">49</xref>,<xref rid="B50-ijms-22-03289" ref-type="bibr">50</xref>]. Three- and one-letter codes of the amino acid sequence are Asn-Glu-Glu-Thr and N-E-E-T, respectively. This is how the protein family is referred to.</p><p>The specific sequence motif, CDGSH [<xref rid="B51-ijms-22-03289" ref-type="bibr">51</xref>], associates with the [2Fe-2S] cluster through coordinates of 3-cysteine (Cys)-1-histidine (His) on the CDGSH domain [<xref rid="B52-ijms-22-03289" ref-type="bibr">52</xref>]. The so-called &#x0201c;CDGSH Iron-Sulfur Domain&#x0201d; represents a common feature of the NEET protein family. In humans, this protein family has three members, CISD1-3 [<xref rid="B53-ijms-22-03289" ref-type="bibr">53</xref>,<xref rid="B54-ijms-22-03289" ref-type="bibr">54</xref>,<xref rid="B55-ijms-22-03289" ref-type="bibr">55</xref>]. &#x0201c;CISD&#x0201d; is named by taking the first word of the common feature &#x0201c;CDGSH Iron-Sulfur Domain&#x0201d;.</p><p>According to morphological characteristics, the NEET protein family is divided into two categories [<xref rid="B56-ijms-22-03289" ref-type="bibr">56</xref>].</p><sec id="sec6dot1-ijms-22-03289"><title>6.1. Class I NEET Protein</title><p>Homodimers with each monomer including one CDGSH domain, e.g., CISD1 and CISD2.</p></sec><sec id="sec6dot2-ijms-22-03289"><title>6.2. Class II NEET Protein</title><p>Monomeric proteins with two CDGSH domains, e.g. CISD3.</p><p>The CDGSH motif is highly evolutionarily conserved. It is found in archaea, bacteria, plants, and humans [<xref rid="B57-ijms-22-03289" ref-type="bibr">57</xref>].</p></sec></sec><sec id="sec7-ijms-22-03289"><title>7. Brief Outline of CISD2 and Biology Perse</title><p>In humans, <italic>CISD2</italic> is tracked at the long arm of chromosome 4 (q24) [<xref rid="B58-ijms-22-03289" ref-type="bibr">58</xref>]. The <italic>CISD2</italic> gene encodes the CISD2 protein. As mentioned earlier, CISD2 acts as the second member of the human NEET family (CISD1-3), and this is how it is named. In the [2Fe-2S] cluster of the CDGSH domain, it mediates the transfer of iron-sulfur clusters or electrons. Thereby, CISD2 serves as a homeostasis regulator under the circumstances of environmental stress.</p><p>CISD2 has been shown to regulate pivotal CNS functions such as acid base homeostasis [<xref rid="B59-ijms-22-03289" ref-type="bibr">59</xref>] and oxidation state [<xref rid="B60-ijms-22-03289" ref-type="bibr">60</xref>]. Cluster transfer leads to the antioxidant effect of NEET proteins [<xref rid="B61-ijms-22-03289" ref-type="bibr">61</xref>]. In general, the [2Fe-2S] cluster of NEET proteins is stable structurally in its reduced state [<xref rid="B60-ijms-22-03289" ref-type="bibr">60</xref>]. Environmental stress promotes changes in oxidation-reduction status of [Fe-S] clusters, leading to cluster transfer [<xref rid="B62-ijms-22-03289" ref-type="bibr">62</xref>,<xref rid="B63-ijms-22-03289" ref-type="bibr">63</xref>,<xref rid="B64-ijms-22-03289" ref-type="bibr">64</xref>]. The CISD2 protein includes cytosolic, transmembrane, and in-organelle domain [<xref rid="B57-ijms-22-03289" ref-type="bibr">57</xref>]. Through the transmembrane helix, each monomer of the homodimeric CISD2 protein can anchor to the outer membrane of mitochondria (OMM) [<xref rid="B59-ijms-22-03289" ref-type="bibr">59</xref>]. CISD2 has been found in the other two subcellular locations, such as endoplasmic reticulum (ER) [<xref rid="B55-ijms-22-03289" ref-type="bibr">55</xref>] and mitochondria-associated ER membranes (MAMs) [<xref rid="B65-ijms-22-03289" ref-type="bibr">65</xref>,<xref rid="B66-ijms-22-03289" ref-type="bibr">66</xref>].</p><p>CISD2 is known to have protective effects against calcium excitotoxicity, apoptosis, OMM breakdown, and resultant mitochondrial anomaly. Via a combination of CISD2 and Bcl-2 together with the inositol 1,4,5-triphosphate (IP3) receptor, CISD2 showed to suppress excitotoxic Ca<sup>2+</sup> escalation at the ER [<xref rid="B67-ijms-22-03289" ref-type="bibr">67</xref>,<xref rid="B68-ijms-22-03289" ref-type="bibr">68</xref>]. CISD2 deficiency has been demonstrated to augment a Ca<sup>2+</sup> surge in ER and cytoplasm in CISD2 knockout mice when compared with wild-type mice [<xref rid="B67-ijms-22-03289" ref-type="bibr">67</xref>]. Moreover, a CISD2-Bcl-2 combination can regulate Bcl-2 to block autophagy or apoptosis in response to stress [<xref rid="B69-ijms-22-03289" ref-type="bibr">69</xref>,<xref rid="B70-ijms-22-03289" ref-type="bibr">70</xref>]. CISD2 enhances the association of Bcl-2 with Beclin-1, and eventually avoids cellular apoptosis. As vital components of OMMs, CISD2 proteins have been shown to mediate the maintenance of mitochondrial integrity [<xref rid="B71-ijms-22-03289" ref-type="bibr">71</xref>]. CISD2 knockout indicates mitochondrial degeneration, autophagy, and subsequent intensification of the aging process in <italic>CISD2</italic><sup>&#x02212;/&#x02212;</sup> mice. Wolfram syndrome 2 (WFS2), an ER/mitochondria-related disease, was found to be linked to the recessive mutation of <italic>CISD2</italic>. Wolfram syndrome is spotlighted by diabetes insipidus, diabetes mellitus, optic atrophy, and deafness (DIDMOAD). This WFS2 subtype may present clinically as diabetes mellitus, optic atrophy, and bleeding tendency [<xref rid="B72-ijms-22-03289" ref-type="bibr">72</xref>].</p><p>Interestingly, CISD2 have various synonyms described by scientists as below. Nutrient-deprivation autophagy factor-1 (NAF-1), endoplasmic reticulum intermembrane small protein (Eris), mitoNEET related 1 (Miner 1), WFS2, zinc finger, and CDGSH-type domain 2 (ZCD2) are common terms which can be used interchangeably. These synonyms indicate important functions of CISD2 in terms of its physiology, subcellular locations, and CDGSH motif.</p></sec><sec id="sec8-ijms-22-03289"><title>8. CISD2 Attenuation in CNS Injuries and Diseases</title><p>In situations such as CNS injuries and diseases, the expression level of CISD2 is definitely reduced.</p><sec id="sec8dot1-ijms-22-03289"><title>8.1. In Vivo Mouse Model of Aging</title><p>Compared with the brain and spinal cord of young mice, the expression of CISD2 was found to be reduced in the corresponding organs of aging mice [<xref rid="B13-ijms-22-03289" ref-type="bibr">13</xref>]. There is an age-dependent reduction in CISD2 expression in the brain, skin, and skeletal muscle of mice [<xref rid="B73-ijms-22-03289" ref-type="bibr">73</xref>].</p></sec><sec id="sec8dot2-ijms-22-03289"><title>8.2. In Vitro Neural Cell Model of Aging</title><p>A long-term primary culture (35 DIV) of astrocytes demonstrated a lower expression of CISD2 and a higher level of pro-inflammatory mediators when compared with the 7 DIV cell group [<xref rid="B13-ijms-22-03289" ref-type="bibr">13</xref>].</p></sec><sec id="sec8dot3-ijms-22-03289"><title>8.3. In Vivo Mouse Model of Acute SCI </title><p>Diminished expression levels of CISD2 were represented in a contused mice spinal cord sustained hemisection [<xref rid="B10-ijms-22-03289" ref-type="bibr">10</xref>,<xref rid="B12-ijms-22-03289" ref-type="bibr">12</xref>].</p></sec><sec id="sec8dot4-ijms-22-03289"><title>8.4. In Vitro Lipopolysaccharide (LPS)&#x02014;Challenged Neural Cells </title><p>Cellular models of lipopolysaccharide (LPS) challenge have been shown to attenuate CISD2 expression in primary astrocytes [<xref rid="B12-ijms-22-03289" ref-type="bibr">12</xref>] and ALT astrocytes (astrocytic cell lines) [<xref rid="B10-ijms-22-03289" ref-type="bibr">10</xref>], respectively. </p><p>It is worth noting that CISD2 reduction can be demonstrated in a variety of neural pathologies including aging related neurodegenerative diseases and traumatic neurological insults. In the role of an NF&#x003ba;B antagonist, CISD2 attenuation results in an enhanced activation of NF&#x003ba;B, exaggerating NF&#x003ba;B-provoked proinflammation and mitochondrial dysfunction.</p></sec></sec><sec id="sec9-ijms-22-03289"><title>9. Searching for CISD2-Elevating Strategy from bioactive Phytochemicals: As a Potential Therapeutic Target for CNS Injuries and Diseases</title><p>Under the circumstances of CNS injuries and diseases, these insults can abolish CISD2 expression and correspondingly lead to NF&#x003ba;B-provoked inflammation and abnormal mitochondrial function.</p><p>Elevation of CISD2 expression augments the inhibitory effects of NF&#x003ba;B activation. NF&#x003ba;B-evoked inflammation and abnormal mitochondrial function underlying the etiology of CNS injuries and diseases are thereby attenuated. Thus, elevation of CISD2 is recommended as a promising therapeutic strategy for CNS injuries and diseases.</p><p>Plenty of naturally occurring phytochemicals with protective effects can originate from plant tissues. These bioactive molecules from natural compounds comprise phenolic compounds, e.g., phenolic acids, flavonoids, conjugated linolenic acid (CLNA), nitrogen-containing compounds, carotenoids, lignans, and terpenes. These phytochemicals possess the inhibitory effect of oxidative cascade and thereby serve as natural antioxidants and potential anti-inflammatory agents [<xref rid="B74-ijms-22-03289" ref-type="bibr">74</xref>,<xref rid="B75-ijms-22-03289" ref-type="bibr">75</xref>]. Below, we address the general characterization of the two categories of bioactive molecules, conjugated fatty acids and polyphenols. With a brief introduction of their protective properties, we extend our discussion to these two phytochemicals, &#x003b1;-ESA (isomer of CLNA) from the seed oil of WBM and curcumin (polyphenolic phytochemical) from the rhizomes of Curcuma longa. The specific CISD2-elevating effect of the two phytochemicals is a newly discovered feature worth being aware of in this review article.</p></sec><sec id="sec10-ijms-22-03289"><title>10. Polyunsaturated Fatty Acids (PUFA)s</title><p>Polyunsaturated fatty acids (PUFAs) remain one of the three main constituent elements of fatty acids (saturated, monounsaturated, and polyunsaturated). This category of fatty acids influences the synthesis of cellular membranes and the function of membrane-bound enzymes/receptors; it also provides energy sources for humans [<xref rid="B76-ijms-22-03289" ref-type="bibr">76</xref>]. PUFAs include the &#x003c9;6 and &#x003c9;3 families, and the main components of each are revealed as follows. Linoleic acid, &#x003b3;-linolenic acid, and arachidonic acid (ARA) are classified as &#x003c9;6 PUFAs, whereas &#x003b1;-linolenic acid, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) are cateogorized as &#x003c9;3 PUFAs [<xref rid="B77-ijms-22-03289" ref-type="bibr">77</xref>] (<xref ref-type="fig" rid="ijms-22-03289-f002">Figure 2</xref>). Belonging to the most common PUFA &#x003c9;6 and &#x003c9;3 families, linoleic acid and &#x003b1;-linolenic acid (so called essential fatty acids) cannot be manufactured by our own human body, but ought to be recruited from the environment as food intake. Linoleic acid and &#x003b1;-linolenic acid are mainly derived from plants [<xref rid="B78-ijms-22-03289" ref-type="bibr">78</xref>]. Linoleic acid can be obtained from most plant seeds in addition to coconut, cocoa, and palm; while on the contrary, &#x003b1;-linolenic acid can be drawn from seeds of flax, rape, chia, perilla, and walnuts as well as through green leafy vegetables.</p><p>This &#x000f9;6 PUFA, linoleic acid, can be transformed into ARA, which potentially enhances proinflammation and increases the risk of cardiovascular disease and metabolic syndrome. On the other hand, &#x000f9;3 PUFA, &#x003b1;-linolenic acid is metabolized to EPA, which could mediate anti-inflammatory effects [<xref rid="B78-ijms-22-03289" ref-type="bibr">78</xref>]. Today, &#x000f9;6 fatty acids, especially linoleic acids, remain the main sources of PUFAs in the Western diet, accounting for &#x0003e;80% of PUFA intake [<xref rid="B79-ijms-22-03289" ref-type="bibr">79</xref>]. Controversy still exists in the role of &#x000f9;6 PUFAs for their pro- or anti-inflammatory effects. In comparison, beneficial impacts of &#x000f9;3 PUFAs in obesity and diabetes mellitus have been addressed in detail [<xref rid="B80-ijms-22-03289" ref-type="bibr">80</xref>]. Changing eating habits is recommended, such as increasing the ratio of (n-3): (n-6) PUFA in the Western diet, which reduces the occurrence of chronic inflammatory diseases [<xref rid="B81-ijms-22-03289" ref-type="bibr">81</xref>].</p></sec><sec id="sec11-ijms-22-03289"><title>11. Conjugated Fatty Acids</title><p>Conjugated fatty acids, as isomers of PUFAs with double bonds in conjugation, have been addressed and have aroused with great interest due to their specific biological activity. This group of conjugated fatty acids, the conjugated linoleic acid (CLA), has been shown to exert superior antioxidant cellular response against oxidative stress when compared to PUFAs [<xref rid="B78-ijms-22-03289" ref-type="bibr">78</xref>].</p><p><xref ref-type="fig" rid="ijms-22-03289-f002">Figure 2</xref> indicates the formation of the two categories of conjugated fatty acids. CLAs and CLNAs are derived from the &#x000f9;6 and &#x000f9;3 PUFAs, linoleic acid and &#x003b1;-linolenic acid, respectively. With the removal of methylene group between double bonds in linoleic and &#x003b1;-linolenic acid, CLAs and CLNAs stand for the main dienoic and trienoic derivatives of the PUFAs, respectively [<xref rid="B82-ijms-22-03289" ref-type="bibr">82</xref>].</p><p>In general, cis-9,trans-11 and trans-10,cis-12 CLA represent the two main categories of CLA isomers [<xref rid="B83-ijms-22-03289" ref-type="bibr">83</xref>]. The former isomer represents the main naturally occurring CLA. In contrast, the later isomer shows better tumor-suppressive effects [<xref rid="B84-ijms-22-03289" ref-type="bibr">84</xref>]. The following conjugated fatty acids stand for the main categories of CLNA isomers: &#x003b1;-eleostearic acid (&#x003b1;-ESA, cis-9,trans-11,trans-13 CLNA), &#x000e2;-eleostearic acid (trans-9,trans-11,trans-13 CLNA), punicic acid (cis-9,trans-11,cis-13 CLNA), catalpic acid (trans-9,trans-11,cis-13 CLNA), calendic acid (trans-8,trans-10,cis-12 CLNA), &#x000e2;-calendic acid (trans-8,trans-10, trans-12 CLNA), and jacaric acid (cis-8,trans-10,cis-12 CLNA) [<xref rid="B85-ijms-22-03289" ref-type="bibr">85</xref>].</p><p>Dietary conjugated fatty acids have been shown to benefit human health. Beef tallow (a kind of ruminant fats), milk fat, and dairy products account for the major sources of CLAs [<xref rid="B86-ijms-22-03289" ref-type="bibr">86</xref>]. However, the CLA content in these foods is only approximately 1% [<xref rid="B87-ijms-22-03289" ref-type="bibr">87</xref>]. CLA can be worked out by alkali isomerization of vegetable oils (such as safflower oil) as dietary additives [<xref rid="B88-ijms-22-03289" ref-type="bibr">88</xref>]. In contrast to CLAs, CLNAs are mainly derived from plants and account for more than 70% of plant fatty acids [<xref rid="B89-ijms-22-03289" ref-type="bibr">89</xref>]. CLNAs are derived from the triglycerides in the seed oils of the families Cucurbitaceae, Punicaceae, Bignoniaceae, Rosaceae, Chrysobalanaceae, Lythraceae, Balasaminaceae, and Euphorbiaceae [<xref rid="B82-ijms-22-03289" ref-type="bibr">82</xref>].</p><p>&#x003b1;-ESA and punicic acid are two typical CLNAs found in seed oils. The amount of punicic acid derived from snake gourd (<italic>Trichosanthes anguina</italic>) seed oil account for about 40% [<xref rid="B82-ijms-22-03289" ref-type="bibr">82</xref>]. It has been shown that bitter melon oil and tung seed oil contain a large amount of &#x003b1;-ESA, about 60% and 70%, respectively [<xref rid="B89-ijms-22-03289" ref-type="bibr">89</xref>]. </p><p>CLNAs have many well-known beneficial effects, covering anti-carcinogenic, anti-adipogenic, anti-inflammatory, and anti-atherosclerotic properties [<xref rid="B90-ijms-22-03289" ref-type="bibr">90</xref>]. In rats, &#x003b1;-ESA and punicic acid can attenuate lipid peroxidation and act as an antioxidant [<xref rid="B91-ijms-22-03289" ref-type="bibr">91</xref>]. In patients with diabetes, &#x003b1;-ESA has been shown to reduce lipid peroxidation in plasma and erythrocyte membrane [<xref rid="B91-ijms-22-03289" ref-type="bibr">91</xref>,<xref rid="B92-ijms-22-03289" ref-type="bibr">92</xref>].</p></sec><sec id="sec12-ijms-22-03289"><title>12. Conversion from CLNA to CLA</title><p>The conversion from CLNA to CLA has been addressed. As isomer of linolenic acid, &#x003b1;-ESA, has been shown to metabolize into cis-9,trans-11 CLA in mice [<xref rid="B84-ijms-22-03289" ref-type="bibr">84</xref>,<xref rid="B93-ijms-22-03289" ref-type="bibr">93</xref>] and rats [<xref rid="B87-ijms-22-03289" ref-type="bibr">87</xref>,<xref rid="B94-ijms-22-03289" ref-type="bibr">94</xref>]. Punicic acid has been shown to transform to cis-9,trans-11 CLA [<xref rid="B95-ijms-22-03289" ref-type="bibr">95</xref>]. The protective effects of CLNAs are related to CLAs, and the pharmacological advantages of CLAs can be considered for CLNAs because of the conversion described above.</p></sec><sec id="sec13-ijms-22-03289"><title>13. Recommended Dosages of Conjugated Fatty Acids</title><p>In the case of a 70 kg human, the suggested daily doses have been addressed as 3&#x02013;6 g/day [<xref rid="B96-ijms-22-03289" ref-type="bibr">96</xref>,<xref rid="B97-ijms-22-03289" ref-type="bibr">97</xref>] for CLA and 2&#x02013;3 g/day for CLNA [<xref rid="B96-ijms-22-03289" ref-type="bibr">96</xref>,<xref rid="B98-ijms-22-03289" ref-type="bibr">98</xref>]. It is recommended that the intake of CLA reach at least 3.4 g/day, which theoretically can reduce the percentage of fat in body and increase lean mass without side effects simultaneously [<xref rid="B97-ijms-22-03289" ref-type="bibr">97</xref>].</p></sec><sec id="sec14-ijms-22-03289"><title>14. Adverse Effects of CLA</title><p>Insulin resistance, increased lipid oxidation, and unsatisfactory serum lipid distribution including increased triglycerides, increased LDL-cholesterol, and decreased HDL content are all related to CLA supplementation [<xref rid="B97-ijms-22-03289" ref-type="bibr">97</xref>].</p></sec><sec id="sec15-ijms-22-03289"><title>15. <italic>Momordica Charantia</italic> L.</title><p><italic>Momordica charantia</italic> L. (scientific name), the so-called bitter melon, belongs to the genus Momordica and Cucurbitaceae family. This plant is also known as balsam pear (English), bitter squash (English), bitter gourd (English), balsam apple (English), concombre africain and margose (French), balsambirne (German), balsamito (Spanish), peria (Malay), paria pare (Indonesian), and karalla (India). </p><p>Bitter melon is an annual vine herb. It germinates best at high temperature, and it is a daily edible vegetable for Asian people. This plant grows in wild tropical and subtropical Africa, Asia, America, and the Caribbean. Moreover, it can also be cultivated [<xref rid="B99-ijms-22-03289" ref-type="bibr">99</xref>].</p><p>Phytochemicals are rich in the fruits and leaves of bitter gourd. This plant is frequently applied in complementary and folk medicine to treat diabetes, hypertension, obesity, cancer, and bacterial as well as viral infections [<xref rid="B100-ijms-22-03289" ref-type="bibr">100</xref>]. In Ayurvedic medicine, every single part of a plant such as seeds, roots, leaves, and especially immature fruits are used for medical applications. The juice is adapted for multiple treatment protocol in joint pain relief, fever, jaundice, liver diseases, as well as skin burns and rashes. Additionally, the entire plant can be used to treat diabetes. In Turkish folk medicine, the oil derived from the ripe fruit, soaked in olive oil, heated by sunlight, is mixed with honey to stabilize gastric ulcers. In African folk medicine, bitter gourd is mainly used for worm infections, inflammation (fruit, seed, and leaf juice), fever, menstruation (leaf), syphilis, rheumatism, and skin disease (root). In the Caribbean, it is administered in the form of leaf decoction or fruit juice to treat diabetes. The leaf decoction is also used to treat high blood pressure and worm infections [<xref rid="B101-ijms-22-03289" ref-type="bibr">101</xref>].</p><p>As a natural antioxidant, bitter melon is a good source of phenolic compounds. Researchers have confirmed that bitter gourd is rich in alkaloids, steroidal glucosides, phenolics, lysophosphatidylcholines (LPC), CLNA isomers, and cucurbitane-type triterpenoids. The favorable effects of bitter gourd come from chemical components including cucurbitane-type triterpenoids, cucurbitane-type triterpene glycoside, phenolic acids, flavonoids, essential oils, fatty acids, amino acids, sterols, saponin constituents, and proteins. The pulp of this plant has a higher antioxidant activity than that of the seeds, which may be attributed to the different extents of phenolic acids and flavonoids [<xref rid="B102-ijms-22-03289" ref-type="bibr">102</xref>]. Current studies have confirmed that bitter gourd has the therapeutic potential of lowering blood sugar, and lowering blood lipids, as well as anti-inflammatory, antioxidant, and anti-carcinogenic effects [<xref rid="B103-ijms-22-03289" ref-type="bibr">103</xref>,<xref rid="B104-ijms-22-03289" ref-type="bibr">104</xref>,<xref rid="B105-ijms-22-03289" ref-type="bibr">105</xref>].</p></sec><sec id="sec16-ijms-22-03289"><title>16. <italic>Momordica Charantia</italic> L. <italic>var. Abbreviata Ser.</italic></title><p><italic>Momordica charantia</italic> L. <italic>var. abbreviata Ser.</italic> (scientific name) is included in the family Cucurbitaceae. This natural plant is commonly named as wild bitter melon. <italic>Momordica charantia</italic> L. <italic>var. abbreviata Ser.</italic> is a wild form of <italic>Momordica charantia</italic> L. This plant is also known as shan ku gua (Mandarin), wild bitter melon (English), wild bitter gourd (English), kakorot (English), and balsampear (English). It is an annual vine. The size of its plant is smaller than that of bitter melon (about one-fifth) [<xref rid="B74-ijms-22-03289" ref-type="bibr">74</xref>]. The color of the plant varies from green to dark green and has a strong bitter taste. In Europe and Asia, WBM can generally be used as a medicinal herb in folk medicine to treat a variety of diseases such as diabetes [<xref rid="B106-ijms-22-03289" ref-type="bibr">106</xref>], alcoholic fatty liver [<xref rid="B107-ijms-22-03289" ref-type="bibr">107</xref>], and to reduce blood pressure [<xref rid="B100-ijms-22-03289" ref-type="bibr">100</xref>].</p><p>The bitter taste of bitter melon is derived from triterpene glycosides and cucurbitacin-like alkaloids. As a rule, immature bitter melon with darker green skin is more bitter, while bitter melon with lighter skin is less bitter. Furthermore, WBM has much higher saponins than bitter melon [<xref rid="B102-ijms-22-03289" ref-type="bibr">102</xref>].</p><p>Pharmacologically, WBM has been addressed for its anti-inflammatory, antioxidant, anti-hyperglycemic, and anti-infectious properties [<xref rid="B108-ijms-22-03289" ref-type="bibr">108</xref>]. The anti-inflammatory and antioxidant effect of WBM is better than that of bitter gourd [<xref rid="B109-ijms-22-03289" ref-type="bibr">109</xref>]. LPS-stimulated RAW 264.7 macrophages showed a decrease in production of proinflammatory PGE2, iNOS, and COX2, along with attenuation of NF&#x00138;B activation after the administration of WBM. Moreover, WBM has been shown to scavenge free radicals [<xref rid="B110-ijms-22-03289" ref-type="bibr">110</xref>] including 2,2-diphenyl-1-picrylhydrazyl (DPPH) and hydroxyl radicals [<xref rid="B74-ijms-22-03289" ref-type="bibr">74</xref>]. </p><sec id="sec16dot1-ijms-22-03289"><title>16.1. &#x003b1;-ESA of WBM </title><p>CLNAs are derived from the seed oils of WBM. As discussed, &#x003b1;-ESA, the isomer of CLNA is widely allocated among members of the family Cucurbitaceae, in particular WBM and bitter gourd. &#x003b1;-ESA is responsible for greater than 60%, and 30% of the total fatty acid in the seed oil is composed of bitter melon [<xref rid="B111-ijms-22-03289" ref-type="bibr">111</xref>] and WBM [<xref rid="B112-ijms-22-03289" ref-type="bibr">112</xref>]. It also accounts for around 19% of the total fatty acid composition of WBM ethyl acetate extracts. In dried and fresh WBM, the amount of &#x003b1;-ESA is 7.1 g/kg and 0.42 g/kg, respectively [<xref rid="B112-ijms-22-03289" ref-type="bibr">112</xref>].</p></sec><sec id="sec16dot2-ijms-22-03289"><title>16.2. Inhibitory Effects of &#x003b1;-ESA on NF&#x003ba;B</title><p>CLA has been demonstrated to act as the ligand of PPAR-&#x003b2; [<xref rid="B113-ijms-22-03289" ref-type="bibr">113</xref>]. As previously mentioned, it is clearly confirmed that &#x003b1;-ESA can be metabolized to CLA. &#x003b1;-ESA can thereby be used as a natural ligand for PPAR-&#x003b2;. The ligation of &#x003b1;-ESA and PPAR-&#x003b2; results in the retardation of I&#x003ba;B degradation and NF-&#x003ba;B activation [<xref rid="B109-ijms-22-03289" ref-type="bibr">109</xref>]. PPAR-&#x003b2; has been shown to downregulate the secretion of transforming necrosis factor-&#x003b1; (TNF-&#x003b1;) in cardiomyocyte culture (via NF-&#x003ba;B inhibition) [<xref rid="B47-ijms-22-03289" ref-type="bibr">47</xref>]. The PPAR-&#x003b2; agonist GW0742 can prevent I&#x003ba;B degradation in a mouse model of bleomycin-induced lung injury (via NF-&#x003ba;B inhibition) [<xref rid="B48-ijms-22-03289" ref-type="bibr">48</xref>]. WBM has been shown to attenuate inflammatory responses in LPS-challenged RAW 264.7 macrophages by inhibiting NF&#x003ba;B activation [<xref rid="B109-ijms-22-03289" ref-type="bibr">109</xref>].</p></sec><sec id="sec16dot3-ijms-22-03289"><title>16.3. CISD2-Elevating Effect of &#x003b1;-ESA in WBM</title><sec id="sec16dot3dot1-ijms-22-03289"><title>16.3.1. In Vitro LPS-Challenged Neural Cells</title><p>LPS-challenged ALT astrocytes incubated with &#x003b1;-ESA demonstrated upregulated injury-attenuated CISD2, along with decreased GAFP and proinflammatory cytokines, when compared to LPS-incubated cells without treatment [<xref rid="B10-ijms-22-03289" ref-type="bibr">10</xref>].</p></sec><sec id="sec16dot3dot2-ijms-22-03289"><title>16.3.2. In Vivo Mouse Model of Acute SCI </title><p>WBM increased injury-attenuated expression levels of CISD2 along with reduced GFAP expression, as indicated in glial deactivation, and suppressed the PPAR-&#x003b2;/I&#x003ba;B/NF-&#x003ba;B signaling pathway [<xref rid="B10-ijms-22-03289" ref-type="bibr">10</xref>].</p></sec></sec></sec><sec id="sec17-ijms-22-03289"><title>17. Passage into the CNS of PUFAs and Conjugated Fatty Acids</title><p>PUFAs [<xref rid="B79-ijms-22-03289" ref-type="bibr">79</xref>] and CLA isomers [<xref rid="B114-ijms-22-03289" ref-type="bibr">114</xref>,<xref rid="B115-ijms-22-03289" ref-type="bibr">115</xref>] have been shown to cross the blood&#x02013;brain barrier (BBB). Evidence clearly demonstrates that PUFAs [<xref rid="B116-ijms-22-03289" ref-type="bibr">116</xref>] and CLA isomers [<xref rid="B117-ijms-22-03289" ref-type="bibr">117</xref>] penetrate into the cerebrospinal fluid (CSF). The results of research on humans indicate that PUFAs can be transferred from the bloodstream to BBB and CSF, thereby affecting the fatty acid concentration in the CNS [<xref rid="B116-ijms-22-03289" ref-type="bibr">116</xref>]. As a result, the acquisition of PUFAs as well as PUFA-derived metabolites such as CLA and CLNA (via CLA conversion) by an enteral or systemic route will reach and cross the BBB, leading to beneficial effects in the CNS.</p></sec><sec id="sec18-ijms-22-03289"><title>18. Polyphenols</title><p>Phenolic compounds are widely derived from nature. The key origins of phenolic compounds are from fruits, vegetables, and bark of woody vascular plants. According to chemical structure, phenolic compounds can be are divided into the following categories: phenolic acids, flavonoids, stilbenes, and lignans [<xref rid="B118-ijms-22-03289" ref-type="bibr">118</xref>]. Phenolic compounds, flavonoids, and resveratrol from stilbenes are the main antioxidative compounds of plant foods [<xref rid="B119-ijms-22-03289" ref-type="bibr">119</xref>].</p><p>Through donation of hydrogen atoms, phenolic compounds make free radicals form a stable resonance pattern, thereby inhibiting chain reactions of free radicals. Accordingly, it can chelate with metals, thereby slowing down the progress of oxidation [<xref rid="B120-ijms-22-03289" ref-type="bibr">120</xref>]. When phenolic compounds inhibit the formation of ROS, they can inhibit inflammation, platelet aggregation, cell apoptosis, and enhance anti-inflammatory effects [<xref rid="B121-ijms-22-03289" ref-type="bibr">121</xref>].</p></sec><sec id="sec19-ijms-22-03289"><title>19. Curcumin as Polyphenolic Phytochemical</title><p>Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione] is a natural compound derived from turmeric (from the root and rhizome of the plant <italic>Curcuma longa</italic> L.). This flowering plant, curcuma longa, belongs to the Ziangiberaceae family, and is used as an alternative medicine for arthritis [<xref rid="B122-ijms-22-03289" ref-type="bibr">122</xref>]. Turmeric is mainly composed of three curcuminoids including curcumin, demethoxycurcumin, and bisdemethoxycurcumin [<xref rid="B123-ijms-22-03289" ref-type="bibr">123</xref>]. The three categories of curcuminoids are compared in structure. As indicated in <xref ref-type="fig" rid="ijms-22-03289-f003">Figure 3</xref>, two, one, and none of the phenyl methoxy groups can be detected in curcumin, demethoxycurcumin, and bisdemethoxycurcumin, respectively. With the phenolic O-H group, curcumin thereby belongs to the phenolic compound in structure. The antioxidant properties of curcumin can be achieved through the structure of hydroxyl groups and phenolic rings [<xref rid="B123-ijms-22-03289" ref-type="bibr">123</xref>,<xref rid="B124-ijms-22-03289" ref-type="bibr">124</xref>].</p><p>Curcuma longa have been widely used as seasonings in many ethnic cuisines in many countries, e.g., Bangladesh, India, and Pakistan. This compound has long been used as anti-inflammatory treatments in traditional Chinese and Ayurvedic medicines [<xref rid="B122-ijms-22-03289" ref-type="bibr">122</xref>]. Curcumin, derived from Curcuma longa, is also popular in food circles as a dietary pigment and Indian spice. Pharmacologically, curcumin has been addressed for its anti-inflammatory, antioxidant, anti-carcinogenic, anti-infectious, hypocholesterolemic, and immunomodulatory activities [<xref rid="B125-ijms-22-03289" ref-type="bibr">125</xref>,<xref rid="B126-ijms-22-03289" ref-type="bibr">126</xref>]. Curcumin has been shown to regulate a variety of critical molecular targets, such as transcription factors, enzymes, cell cycle proteins, receptors, and cell surface adhesion molecules [<xref rid="B127-ijms-22-03289" ref-type="bibr">127</xref>,<xref rid="B128-ijms-22-03289" ref-type="bibr">128</xref>].</p><sec id="sec19dot1-ijms-22-03289"><title>19.1. Toxic Dosage of Curcumin</title><p>When the content of curcumin-based essential oil complex exceeds 5000 mg/kg, no acute toxicity is shown in mice [<xref rid="B129-ijms-22-03289" ref-type="bibr">129</xref>]. Curcumin has been shown to have no toxicity at doses exceeding 2 g/kg body weight in rats [<xref rid="B130-ijms-22-03289" ref-type="bibr">130</xref>]. </p><p>No side effects have been shown following the use of 8000 mg curcumin daily for three months [<xref rid="B131-ijms-22-03289" ref-type="bibr">131</xref>]. In human clinical trials, the safe dose of curcumin has been addressed to be 10 grams per day [<xref rid="B132-ijms-22-03289" ref-type="bibr">132</xref>]. Specifically, the acceptable daily intake (ADI) of curcumin is 0&#x02013;3 mg/kg body weight (reports of the Joint United Nations and World Health Organization Expert Committee on Food Additives, JECFA; European Food Safety Authority, EFSA) [<xref rid="B133-ijms-22-03289" ref-type="bibr">133</xref>].</p></sec><sec id="sec19dot2-ijms-22-03289"><title>19.2. Adverse Effects of Curcumin</title><p>Patients may experience nausea, diarrhea, increased serum alkaline phosphatase, and lactate dehydrogenase when ingesting over 450&#x02013;3600 mg curcumin daily for 1&#x02013;4 months. If one takes a single-dose of 500&#x02013;12,000 mg (dose response study), symptoms and signs such as diarrhea, headache, skin rash, and yellowish stool can occur [<xref rid="B133-ijms-22-03289" ref-type="bibr">133</xref>]. Further gastrointestinal discomfort, dyspnea, skin itching, and swelling may arise following high-dose curcumin intake [<xref rid="B132-ijms-22-03289" ref-type="bibr">132</xref>].</p></sec><sec id="sec19dot3-ijms-22-03289"><title>19.3. Anti-Inflammation of Curcumin</title><p>Curcumin has been shown to decrease injury-induced neuroinflammation. Injury-triggered inflammatory mediators such as the pro-inflammatory transcription factor activator protein-1 (AP-1) and iNOS can both be attenuated after curcumin administration [<xref rid="B134-ijms-22-03289" ref-type="bibr">134</xref>]. Injury-stimulated glial activation is indicated as expression of glial fibrillary acid protein (GFAP) [<xref rid="B135-ijms-22-03289" ref-type="bibr">135</xref>] and production of injury-induced RANTES in astrocytes which is reduced in rats following SCI [<xref rid="B136-ijms-22-03289" ref-type="bibr">136</xref>]. Lastly, curcumin impaired the activation of microglia and astrocytes and decreased the apoptosis induced by exposure to ozone (O3) in the hippocampus of rats [<xref rid="B137-ijms-22-03289" ref-type="bibr">137</xref>].</p></sec><sec id="sec19dot4-ijms-22-03289"><title>19.4. Prevention of Mitochondrial Dysfunction of Curcumin</title><p>Ultraviolet irradiation-induced apoptosis, e.g., impaired mitochondrial membrane potential, cytochrome C release, and ROS production can be prevented after curcumin treatment [<xref rid="B138-ijms-22-03289" ref-type="bibr">138</xref>]. Curcumin has been shown to scavenge ROS via electron donation from the phenolic hydroxyl group [<xref rid="B139-ijms-22-03289" ref-type="bibr">139</xref>]. The antioxidant effects of curcumin involved the decrease in lipid peroxidation and scavenging of NO [<xref rid="B140-ijms-22-03289" ref-type="bibr">140</xref>].</p></sec><sec id="sec19dot5-ijms-22-03289"><title>19.5. Inhibitory Effect of Curcumin on NF&#x003ba;B </title><p>Curcumin has been well documented for antagonization of NF&#x003ba;B activation, along with inhibiting the aggregation of &#x003b2;-amyloid [<xref rid="B141-ijms-22-03289" ref-type="bibr">141</xref>] and preventing the production of proinflammatory mediators, such as AP-1, TNF&#x003b1;, IL1&#x003b2;, and iNOS [<xref rid="B134-ijms-22-03289" ref-type="bibr">134</xref>,<xref rid="B142-ijms-22-03289" ref-type="bibr">142</xref>].</p></sec><sec id="sec19dot6-ijms-22-03289"><title>19.6. CISD2-Elevating Effect of Curcumin</title><sec id="sec19dot6dot1-ijms-22-03289"><title>19.6.1. In Vivo Mouse Model of Aging</title><p>Curcumin-managed mice demonstrated a remarkable elevation in CISD2 protein expression in the spinal cord, in contrast to their unmanaged counterparts [<xref rid="B13-ijms-22-03289" ref-type="bibr">13</xref>].</p></sec><sec id="sec19dot6dot2-ijms-22-03289"><title>19.6.2. In Vitro Neural Cell Model of Aging </title><p>Curcumin-treated extreme aging astrocytes (35 <italic>DIV</italic>) demonstrated CISD2-elevating effect and reduced extent of neuroinflammation, as indicated in an attenuation of iNOS and RANTES expression levels, when compared to cells untreated with curcumin [<xref rid="B13-ijms-22-03289" ref-type="bibr">13</xref>].</p></sec><sec id="sec19dot6dot3-ijms-22-03289"><title>19.6.3. In Vivo Mouse Model of Acute SCI </title><p>Curcumin treatment can augment injury-attenuated CISD2 expression as well as CISD2-positive cells in mice following SCIs [<xref rid="B12-ijms-22-03289" ref-type="bibr">12</xref>].</p></sec><sec id="sec19dot6dot4-ijms-22-03289"><title>19.6.4. In Vitro LPS-Challenged Neural Cells</title><p>LPS-challenged astrocytes with curcumin treatment demonstrated a significant increase in CISD2 expression when compared to LPS-challenged astrocytes untreated with curcumin [<xref rid="B12-ijms-22-03289" ref-type="bibr">12</xref>].</p></sec></sec></sec><sec id="sec20-ijms-22-03289"><title>20. Passage into the CNS of Curcumin </title><p>The following evidence proves that curcumin plays a protective role in CNS. (1) Curcumin passes easily into the BBB [<xref rid="B141-ijms-22-03289" ref-type="bibr">141</xref>]. (2) The ability to increase the permeability of the BBB during brain ischemia [<xref rid="B143-ijms-22-03289" ref-type="bibr">143</xref>]. (3) The ability to enhance the integrity of the blood&#x02013;spinal cord barrier after SCI [<xref rid="B144-ijms-22-03289" ref-type="bibr">144</xref>]. (4) The percolation of curcumin into the CSF [<xref rid="B145-ijms-22-03289" ref-type="bibr">145</xref>]. CSF circulates in the subarachnoid space around the CNS, so curcumin is delivered with ease to the brain and spinal cord.</p></sec><sec id="sec21-ijms-22-03289"><title>21. CNS Pathology-CISD2-NF&#x003ba;B Axis and Perspectives</title><p>In the CNS, glial cells can be abnormally activated during aging, neurodegenerative disease, and neurotrauma. Glia-mediated neuroinflammation and mitochondrial dysfunction along with CISD2 decline and NF&#x003ba;B activation are implicated in CNS injuries and diseases. CISD2, as a NEET and iron-sulfur protein with a [2Fe-2S] cluster, has been shown to modulate various important proteins, such as Bcl2, PPAR-&#x003b2;, and NF&#x003ba;B. CISD2 can regulate critical physiological functions, such as apoptosis or mitochondrial Fe/ROS/Fe-S homeostasis. The unique characteristic of this protective protein is highlighted throughout this article, acting as an NF&#x003ba;B antagonist. Previous in vitro data showed that siCISD2-transfected neural cells (untreated or treated with LPS) commonly exhibited inflammatory responses, pronounced mitochondrial dysfunction including lower DeltaPsi (m), higher ROS levels, more extensive apoptosis, and a reduction in cell survival. Since NF&#x003ba;B mediates pro-inflammatory cascades and mitochondrial function, injury-driven pathological decline of CISD2 undoubtedly weakens the inhibitory effect on NF&#x003ba;B activation, causing a wide range of harmful effects.</p><p>Under circumstances of CNS injuries and diseases, how to elevate insult-attenuated CISD2 expression holds promises for treatment. Phytochemicals from natural compounds beneficial to CISD2-elevation can be considered and applied to manage CNS injuries and diseases. Natural phytochemicals, &#x003b1;-ESA (CLNA isomer from WBM) and curcumin, both are able to enter the CNS through the BBB, which is conducive to this axis of CNS pathology&#x02013;CISD2-NF&#x003ba;B (<xref ref-type="fig" rid="ijms-22-03289-f001">Figure 1</xref>). The above two phytochemicals, exerting neuromodulatory effects on CISD2 elevation, can be considered to be applied in CNS injuries and diseases.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>W.-M.K.: original draft, investigation and formal analysis; M.-S.L.: conceptualization, supervision, formal analysis and writing&#x02014;review and editing. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-ijms-22-03289"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>A.</given-names></name><name><surname>Shang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Bacon</surname><given-names>E.R.</given-names></name><name><surname>Yin</surname><given-names>F.</given-names></name><name><surname>Brinton</surname><given-names>R.D.</given-names></name></person-group><article-title>Dynamic neuroimmune profile during mid-life aging in the female brain and implications for Alzheimer risk</article-title><source>iScience</source><year>2020</year><volume>23</volume><fpage>101829</fpage><pub-id pub-id-type="doi">10.1016/j.isci.2020.101829</pub-id><pub-id pub-id-type="pmid">33319170</pub-id></element-citation></ref><ref id="B2-ijms-22-03289"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname><given-names>L.</given-names></name><name><surname>Ghezzi</surname><given-names>L.</given-names></name><name><surname>Cross</surname><given-names>A.H.</given-names></name><name><surname>Piccio</surname><given-names>L.</given-names></name></person-group><article-title>Effects of dietary restriction on neuroinflammation in neurodegenerative diseases</article-title><source>J. Exp. Med.</source><year>2021</year><fpage>218</fpage></element-citation></ref><ref id="B3-ijms-22-03289"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Hou</surname><given-names>L.</given-names></name><name><surname>Jing</surname><given-names>L.</given-names></name><name><surname>Ruan</surname><given-names>Z.</given-names></name><name><surname>Peng</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Hong</surname><given-names>J.S.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name></person-group><article-title>Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson&#x02019;s disease model</article-title><source>J. Neuroinflammation</source><year>2021</year><volume>18</volume><fpage>4</fpage><pub-id pub-id-type="doi">10.1186/s12974-020-02065-z</pub-id><pub-id pub-id-type="pmid">33402167</pub-id></element-citation></ref><ref id="B4-ijms-22-03289"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witcher</surname><given-names>K.G.</given-names></name><name><surname>Bray</surname><given-names>C.E.</given-names></name><name><surname>Chunchai</surname><given-names>T.</given-names></name><name><surname>Zhao</surname><given-names>F.</given-names></name><name><surname>O&#x02019;Neil</surname><given-names>S.M.</given-names></name><name><surname>Gordillo</surname><given-names>A.J.</given-names></name><name><surname>Campbell</surname><given-names>W.A.</given-names></name><name><surname>McKim</surname><given-names>D.B.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Dziabis</surname><given-names>J.E.</given-names></name><etal/></person-group><article-title>Traumatic brain injury causes chronic cortical inflammation and neuronal dysfunction mediated by microglia</article-title><source>J. Neurosci.</source><year>2021</year><volume>41</volume><fpage>1597</fpage><lpage>1616</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2469-20.2020</pub-id><?supplied-pmid 33452227?><pub-id pub-id-type="pmid">33452227</pub-id></element-citation></ref><ref id="B5-ijms-22-03289"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahbazi</surname><given-names>S.</given-names></name><name><surname>Zakerali</surname><given-names>T.</given-names></name><name><surname>Frycz</surname><given-names>B.A.</given-names></name><name><surname>Kaur</surname><given-names>J.</given-names></name></person-group><article-title>The critical role of piperamide derivative D4 in the regulation of inflammatory response by the microglia and astrocytic glial cells</article-title><source>Biomed. Pharmacother.</source><year>2020</year><volume>132</volume><fpage>110895</fpage><pub-id pub-id-type="doi">10.1016/j.biopha.2020.110895</pub-id><?supplied-pmid 33113430?><pub-id pub-id-type="pmid">33113430</pub-id></element-citation></ref><ref id="B6-ijms-22-03289"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agrawal</surname><given-names>I.</given-names></name><name><surname>Jha</surname><given-names>S.</given-names></name></person-group><article-title>Mitochondrial dysfunction and Alzheimer&#x02019;s disease: Role of microglia</article-title><source>Front. Aging Neurosci.</source><year>2020</year><volume>12</volume><fpage>252</fpage><pub-id pub-id-type="doi">10.3389/fnagi.2020.00252</pub-id><?supplied-pmid 32973488?><pub-id pub-id-type="pmid">32973488</pub-id></element-citation></ref><ref id="B7-ijms-22-03289"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picca</surname><given-names>A.</given-names></name><name><surname>Calvani</surname><given-names>R.</given-names></name><name><surname>Coelho-Junior</surname><given-names>H.J.</given-names></name><name><surname>Landi</surname><given-names>F.</given-names></name><name><surname>Bernabei</surname><given-names>R.</given-names></name><name><surname>Marzetti</surname><given-names>E.</given-names></name></person-group><article-title>Mitochondrial dysfunction, oxidative stress, and neuroinflammation: Intertwined roads to neurodegeneration</article-title><source>Antioxidants</source><year>2020</year><volume>9</volume><elocation-id>647</elocation-id><pub-id pub-id-type="doi">10.3390/antiox9080647</pub-id></element-citation></ref><ref id="B8-ijms-22-03289"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nisr</surname><given-names>R.B.</given-names></name><name><surname>Shah</surname><given-names>D.S.</given-names></name><name><surname>Ganley</surname><given-names>I.G.</given-names></name><name><surname>Hundal</surname><given-names>H.S.</given-names></name></person-group><article-title>Proinflammatory NFkB signalling promotes mitochondrial dysfunction in skeletal muscle in response to cellular fuel overloading</article-title><source>Cell. Mol. Life Sci.</source><year>2019</year><volume>76</volume><fpage>4887</fpage><lpage>4904</lpage><pub-id pub-id-type="doi">10.1007/s00018-019-03148-8</pub-id><pub-id pub-id-type="pmid">31101940</pub-id></element-citation></ref><ref id="B9-ijms-22-03289"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laforge</surname><given-names>M.</given-names></name><name><surname>Rodrigues</surname><given-names>V.</given-names></name><name><surname>Silvestre</surname><given-names>R.</given-names></name><name><surname>Gautier</surname><given-names>C.</given-names></name><name><surname>Weil</surname><given-names>R.</given-names></name><name><surname>Corti</surname><given-names>O.</given-names></name><name><surname>Estaquier</surname><given-names>J.</given-names></name></person-group><article-title>NF-&#x003ba;B pathway controls mitochondrial dynamics</article-title><source>Cell Death. Differ.</source><year>2016</year><volume>23</volume><fpage>89</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1038/cdd.2015.42</pub-id><pub-id pub-id-type="pmid">26024391</pub-id></element-citation></ref><ref id="B10-ijms-22-03289"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kung</surname><given-names>W.M.</given-names></name><name><surname>Lin</surname><given-names>C.C.</given-names></name><name><surname>Kuo</surname><given-names>C.Y.</given-names></name><name><surname>Juin</surname><given-names>Y.C.</given-names></name><name><surname>Wu</surname><given-names>P.C.</given-names></name><name><surname>Lin</surname><given-names>M.S.</given-names></name></person-group><article-title>Wild bitter melon exerts anti-inflammatory effects by upregulating injury-attenuated CISD2 expression following spinal cord injury</article-title><source>Behav. Neurol.</source><year>2020</year><volume>2020</volume><fpage>1080521</fpage><pub-id pub-id-type="doi">10.1155/2020/1080521</pub-id><pub-id pub-id-type="pmid">33062068</pub-id></element-citation></ref><ref id="B11-ijms-22-03289"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kung</surname><given-names>W.M.</given-names></name><name><surname>Chang</surname><given-names>C.J.</given-names></name><name><surname>Chen</surname><given-names>T.Y.</given-names></name><name><surname>Lin</surname><given-names>M.S.</given-names></name></person-group><article-title>Cryogen spray cooling mitigates inflammation and injury-induced CISD2 decline in rat spinal cord hemisection model</article-title><source>J. Integr. Neurosci.</source><year>2020</year><volume>19</volume><fpage>619</fpage><lpage>628</lpage><pub-id pub-id-type="doi">10.31083/j.jin.2020.04.255</pub-id><pub-id pub-id-type="pmid">33378836</pub-id></element-citation></ref><ref id="B12-ijms-22-03289"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C.C.</given-names></name><name><surname>Chiang</surname><given-names>T.H.</given-names></name><name><surname>Chen</surname><given-names>W.J.</given-names></name><name><surname>Sun</surname><given-names>Y.Y.</given-names></name><name><surname>Lee</surname><given-names>Y.H.</given-names></name><name><surname>Lin</surname><given-names>M.S.</given-names></name></person-group><article-title>CISD2 serves a novel role as a suppressor of nitric oxide signalling and curcumin increases CISD2 expression in spinal cord injuries</article-title><source>Injury</source><year>2015</year><volume>46</volume><fpage>2341</fpage><lpage>2350</lpage><pub-id pub-id-type="doi">10.1016/j.injury.2015.07.040</pub-id><pub-id pub-id-type="pmid">26387034</pub-id></element-citation></ref><ref id="B13-ijms-22-03289"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C.C.</given-names></name><name><surname>Chiang</surname><given-names>T.H.</given-names></name><name><surname>Sun</surname><given-names>Y.Y.</given-names></name><name><surname>Lin</surname><given-names>M.S.</given-names></name></person-group><article-title>Protective effects of CISD2 and influence of curcumin on CISD2 expression in aged animals and inflammatory cell model</article-title><source>Nutrients</source><year>2019</year><volume>11</volume><elocation-id>700</elocation-id><pub-id pub-id-type="doi">10.3390/nu11030700</pub-id></element-citation></ref><ref id="B14-ijms-22-03289"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshizaki</surname><given-names>S.</given-names></name><name><surname>Tamaru</surname><given-names>T.</given-names></name><name><surname>Hara</surname><given-names>M.</given-names></name><name><surname>Kijima</surname><given-names>K.</given-names></name><name><surname>Tanaka</surname><given-names>M.</given-names></name><name><surname>Konno</surname><given-names>D.J.</given-names></name><name><surname>Matsumoto</surname><given-names>Y.</given-names></name><name><surname>Nakashima</surname><given-names>Y.</given-names></name><name><surname>Okada</surname><given-names>S.</given-names></name></person-group><article-title>Microglial inflammation after chronic spinal cord injury is enhanced by reactive astrocytes via the fibronectin/ /&#x003b2;1 integrin pathway</article-title><source>J. Neuroinflamm.</source><year>2021</year><volume>18</volume><fpage>12</fpage><pub-id pub-id-type="doi">10.1186/s12974-020-02059-x</pub-id><?supplied-pmid 33407620?><pub-id pub-id-type="pmid">33407620</pub-id></element-citation></ref><ref id="B15-ijms-22-03289"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>You</surname><given-names>Z.</given-names></name></person-group><article-title>Switching of the microglial activation phenotype is a possible treatment for depression disorder</article-title><source>Front. Cell. Neurosci.</source><year>2018</year><volume>12</volume><fpage>306</fpage><pub-id pub-id-type="doi">10.3389/fncel.2018.00306</pub-id><?supplied-pmid 30459555?><pub-id pub-id-type="pmid">30459555</pub-id></element-citation></ref><ref id="B16-ijms-22-03289"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wake</surname><given-names>H.</given-names></name><name><surname>Moorhouse</surname><given-names>A.J.</given-names></name><name><surname>Nabekura</surname><given-names>J.</given-names></name></person-group><article-title>Functions of microglia in the central nervous system&#x02014;Beyond the immune response</article-title><source>Neuron Glia Biol.</source><year>2011</year><volume>7</volume><fpage>47</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1017/S1740925X12000063</pub-id><pub-id pub-id-type="pmid">22613055</pub-id></element-citation></ref><ref id="B17-ijms-22-03289"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baek</surname><given-names>H.</given-names></name><name><surname>Lim</surname><given-names>C.S.</given-names></name><name><surname>Byun</surname><given-names>H.S.</given-names></name><name><surname>Cho</surname><given-names>H.S.</given-names></name><name><surname>Lee</surname><given-names>Y.R.</given-names></name><name><surname>Shin</surname><given-names>Y.S.</given-names></name><name><surname>Kim</surname><given-names>H.W.</given-names></name><name><surname>Jeon</surname><given-names>B.H.</given-names></name><name><surname>Kim</surname><given-names>D.W.</given-names></name><name><surname>Hong</surname><given-names>J.</given-names></name><etal/></person-group><article-title>The anti-inflammatory role of extranuclear apurinic/apyrimidinic endonuclease 1/redox effector factor-1 in reactive astrocytes</article-title><source>Mol. Brain</source><year>2016</year><volume>9</volume><fpage>99</fpage><pub-id pub-id-type="doi">10.1186/s13041-016-0280-9</pub-id><?supplied-pmid 27986089?><pub-id pub-id-type="pmid">27986089</pub-id></element-citation></ref><ref id="B18-ijms-22-03289"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>M.H.</given-names></name><name><surname>Suk</surname><given-names>K.</given-names></name></person-group><article-title>Mitochondrial dynamics and bioenergetic alteration during inflammatory activation of astrocytes</article-title><source>Front. Aging Neurosci.</source><year>2020</year><volume>12</volume><fpage>614410</fpage><pub-id pub-id-type="doi">10.3389/fnagi.2020.614410</pub-id><pub-id pub-id-type="pmid">33362533</pub-id></element-citation></ref><ref id="B19-ijms-22-03289"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eilert-Olsen</surname><given-names>M.</given-names></name><name><surname>Hjukse</surname><given-names>J.B.</given-names></name><name><surname>Thoren</surname><given-names>A.E.</given-names></name><name><surname>Tang</surname><given-names>W.</given-names></name><name><surname>Enger</surname><given-names>R.</given-names></name><name><surname>Jensen</surname><given-names>V.</given-names></name><name><surname>Pettersen</surname><given-names>K.H.</given-names></name><name><surname>Nagelhus</surname><given-names>E.A.</given-names></name></person-group><article-title>Astroglial endfeet exhibit distinct Ca(2+) signals during hypoosmotic conditions</article-title><source>Glia</source><year>2019</year><volume>67</volume><fpage>2399</fpage><lpage>2409</lpage><pub-id pub-id-type="doi">10.1002/glia.23692</pub-id><pub-id pub-id-type="pmid">31350866</pub-id></element-citation></ref><ref id="B20-ijms-22-03289"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>H.S.</given-names></name><name><surname>Koh</surname><given-names>S.H.</given-names></name></person-group><article-title>Neuroinflammation in neurodegenerative disorders: The roles of microglia and astrocytes</article-title><source>Transl. Neurodegener.</source><year>2020</year><volume>9</volume><fpage>42</fpage><pub-id pub-id-type="doi">10.1186/s40035-020-00221-2</pub-id><pub-id pub-id-type="pmid">33239064</pub-id></element-citation></ref><ref id="B21-ijms-22-03289"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f3;pez-Ot&#x000ed;n</surname><given-names>C.</given-names></name><name><surname>Blasco</surname><given-names>M.A.</given-names></name><name><surname>Partridge</surname><given-names>L.</given-names></name><name><surname>Serrano</surname><given-names>M.</given-names></name><name><surname>Kroemer</surname><given-names>G.</given-names></name></person-group><article-title>The hallmarks of aging</article-title><source>Cell</source><year>2013</year><volume>153</volume><fpage>1194</fpage><lpage>1217</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.05.039</pub-id><pub-id pub-id-type="pmid">23746838</pub-id></element-citation></ref><ref id="B22-ijms-22-03289"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>Y.</given-names></name><name><surname>Dan</surname><given-names>X.</given-names></name><name><surname>Babbar</surname><given-names>M.</given-names></name><name><surname>Wei</surname><given-names>Y.</given-names></name><name><surname>Hasselbalch</surname><given-names>S.G.</given-names></name><name><surname>Croteau</surname><given-names>D.L.</given-names></name><name><surname>Bohr</surname><given-names>V.A.</given-names></name></person-group><article-title>Ageing as a risk factor for neurodegenerative disease</article-title><source>Nat. Rev. Neurol.</source><year>2019</year><volume>15</volume><fpage>565</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1038/s41582-019-0244-7</pub-id><pub-id pub-id-type="pmid">31501588</pub-id></element-citation></ref><ref id="B23-ijms-22-03289"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanada</surname><given-names>F.</given-names></name><name><surname>Taniyama</surname><given-names>Y.</given-names></name><name><surname>Muratsu</surname><given-names>J.</given-names></name><name><surname>Otsu</surname><given-names>R.</given-names></name><name><surname>Shimizu</surname><given-names>H.</given-names></name><name><surname>Rakugi</surname><given-names>H.</given-names></name><name><surname>Morishita</surname><given-names>R.</given-names></name></person-group><article-title>Source of chronic inflammation in aging</article-title><source>Front. Cardiovasc. Med.</source><year>2018</year><volume>5</volume><fpage>12</fpage><pub-id pub-id-type="doi">10.3389/fcvm.2018.00012</pub-id><?supplied-pmid 29564335?><pub-id pub-id-type="pmid">29564335</pub-id></element-citation></ref><ref id="B24-ijms-22-03289"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wyss-Coray</surname><given-names>T.</given-names></name></person-group><article-title>Ageing, neurodegeneration and brain rejuvenation</article-title><source>Nature</source><year>2016</year><volume>539</volume><fpage>180</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1038/nature20411</pub-id><?supplied-pmid 27830812?><pub-id pub-id-type="pmid">27830812</pub-id></element-citation></ref><ref id="B25-ijms-22-03289"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matt</surname><given-names>S.M.</given-names></name><name><surname>Johnson</surname><given-names>R.W.</given-names></name></person-group><article-title>Neuro-immune dysfunction during brain aging: New insights in microglial cell regulation</article-title><source>Curr. Opin. Pharmacol.</source><year>2016</year><volume>26</volume><fpage>96</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.coph.2015.10.009</pub-id><pub-id pub-id-type="pmid">26595306</pub-id></element-citation></ref><ref id="B26-ijms-22-03289"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olmedillas Del</surname><given-names>M.M.</given-names></name><name><surname>Asavapanumas</surname><given-names>N.</given-names></name><name><surname>Uzc&#x000e1;tegui</surname><given-names>N.L.</given-names></name><name><surname>Garaschuk</surname><given-names>O.</given-names></name></person-group><article-title>Healthy brain aging modifies microglial calcium signaling in vivo</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>589</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20030589</pub-id><?supplied-pmid 30704036?><pub-id pub-id-type="pmid">30704036</pub-id></element-citation></ref><ref id="B27-ijms-22-03289"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tcw</surname><given-names>J.</given-names></name><name><surname>Goate</surname><given-names>A.M.</given-names></name></person-group><article-title>Genetics of &#x003b2;-amyloid precursor protein in Alzheimer&#x02019;s disease</article-title><source>Cold Spring Harb. Perspect. Med.</source><year>2017</year><volume>7</volume><fpage>a024539</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a024539</pub-id><pub-id pub-id-type="pmid">28003277</pub-id></element-citation></ref><ref id="B28-ijms-22-03289"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>B.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Nussinov</surname><given-names>R.</given-names></name></person-group><article-title>Conformational selection in amyloid-based immunotherapy: Survey of crystal structures of antibody-amyloid complexes</article-title><source>Biochim. Biophys. Acta</source><year>2016</year><volume>1860</volume><fpage>2672</fpage><lpage>2681</lpage><pub-id pub-id-type="doi">10.1016/j.bbagen.2016.05.040</pub-id><pub-id pub-id-type="pmid">27266343</pub-id></element-citation></ref><ref id="B29-ijms-22-03289"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greer</surname><given-names>J.E.</given-names></name><name><surname>Hanell</surname><given-names>A.</given-names></name><name><surname>McGinn</surname><given-names>M.J.</given-names></name><name><surname>Povlishock</surname><given-names>J.T.</given-names></name></person-group><article-title>Mild traumatic brain injury in the mouse induces axotomy primarily within the axon initial segment</article-title><source>Acta Neuropathol.</source><year>2013</year><volume>126</volume><fpage>59</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1007/s00401-013-1119-4</pub-id><pub-id pub-id-type="pmid">23595276</pub-id></element-citation></ref><ref id="B30-ijms-22-03289"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>N.</given-names></name><name><surname>Chugh</surname><given-names>H.</given-names></name><name><surname>Sakharkar</surname><given-names>M.K.</given-names></name><name><surname>Dhawan</surname><given-names>U.</given-names></name><name><surname>Chidambaram</surname><given-names>S.B.</given-names></name><name><surname>Chandra</surname><given-names>R.</given-names></name></person-group><article-title>Neuroinflammation mechanisms and phytotherapeutic intervention: A systematic review</article-title><source>ACS Chem. Neurosci.</source><year>2020</year><volume>11</volume><fpage>3707</fpage><lpage>3731</lpage><pub-id pub-id-type="doi">10.1021/acschemneuro.0c00427</pub-id><pub-id pub-id-type="pmid">33146995</pub-id></element-citation></ref><ref id="B31-ijms-22-03289"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>X.</given-names></name><name><surname>Jiang</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Fang</surname><given-names>L.</given-names></name><name><surname>Qian</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Kong</surname><given-names>R.</given-names></name></person-group><article-title>Treatment with 5-methoxytryptophan attenuates microglia-induced neuroinflammation in spinal cord trauma</article-title><source>Int. Immunopharmacol.</source><year>2020</year><volume>88</volume><fpage>106988</fpage><pub-id pub-id-type="doi">10.1016/j.intimp.2020.106988</pub-id><?supplied-pmid 33182019?><pub-id pub-id-type="pmid">33182019</pub-id></element-citation></ref><ref id="B32-ijms-22-03289"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surgucheva</surname><given-names>I.</given-names></name><name><surname>He</surname><given-names>S.</given-names></name><name><surname>Rich</surname><given-names>M.C.</given-names></name><name><surname>Sharma</surname><given-names>R.</given-names></name><name><surname>Ninkina</surname><given-names>N.N.</given-names></name><name><surname>Stahel</surname><given-names>P.F.</given-names></name><name><surname>Surguchov</surname><given-names>A.</given-names></name></person-group><article-title>Role of synucleins in traumatic brain injury&#x02014;An experimental in vitro and in vivo study in mice</article-title><source>Mol. Cell. Neurosci.</source><year>2014</year><volume>63</volume><fpage>114</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/j.mcn.2014.10.005</pub-id><?supplied-pmid 25447944?><pub-id pub-id-type="pmid">25447944</pub-id></element-citation></ref><ref id="B33-ijms-22-03289"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L.R.</given-names></name><name><surname>Liu</surname><given-names>J.C.</given-names></name><name><surname>Bao</surname><given-names>J.S.</given-names></name><name><surname>Bai</surname><given-names>Q.Q.</given-names></name><name><surname>Wang</surname><given-names>G.Q.</given-names></name></person-group><article-title>Interaction of microglia and astrocytes in the neurovascular unit</article-title><source>Front. Immunol.</source><year>2020</year><volume>11</volume><fpage>1024</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2020.01024</pub-id><?supplied-pmid 32733433?><pub-id pub-id-type="pmid">32733433</pub-id></element-citation></ref><ref id="B34-ijms-22-03289"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venegas</surname><given-names>C.</given-names></name><name><surname>Heneka</surname><given-names>M.T.</given-names></name></person-group><article-title>Danger-associated molecular patterns in Alzheimer&#x02019;s disease</article-title><source>J. Leukoc. Biol.</source><year>2017</year><volume>101</volume><fpage>87</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1189/jlb.3MR0416-204R</pub-id><?supplied-pmid 28049142?><pub-id pub-id-type="pmid">28049142</pub-id></element-citation></ref><ref id="B35-ijms-22-03289"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McElroy</surname><given-names>P.B.</given-names></name><name><surname>Liang</surname><given-names>L.P.</given-names></name><name><surname>Day</surname><given-names>B.J.</given-names></name><name><surname>Patel</surname><given-names>M.</given-names></name></person-group><article-title>Scavenging reactive oxygen species inhibits status epilepticus-induced neuroinflammation</article-title><source>Exp. Neurol.</source><year>2017</year><volume>298</volume><fpage>13</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.expneurol.2017.08.009</pub-id><?supplied-pmid 28822838?><pub-id pub-id-type="pmid">28822838</pub-id></element-citation></ref><ref id="B36-ijms-22-03289"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>D.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name></person-group><article-title>Sirtuin 3 attenuates neuroinflammation-induced apoptosis in BV-2 microglia</article-title><source>Aging (Albany)</source><year>2019</year><volume>11</volume><fpage>9075</fpage><lpage>9089</lpage><pub-id pub-id-type="doi">10.18632/aging.102375</pub-id></element-citation></ref><ref id="B37-ijms-22-03289"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Missiroli</surname><given-names>S.</given-names></name><name><surname>Genovese</surname><given-names>I.</given-names></name><name><surname>Perrone</surname><given-names>M.</given-names></name><name><surname>Vezzani</surname><given-names>B.</given-names></name><name><surname>Vitto VA</surname><given-names>M.</given-names></name><name><surname>Giorgi</surname><given-names>C.</given-names></name></person-group><article-title>The role of mitochondria in inflammation: From cancer to neurodegenerative disorders</article-title><source>J. Clin. Med.</source><year>2020</year><volume>9</volume><elocation-id>740</elocation-id><pub-id pub-id-type="doi">10.3390/jcm9030740</pub-id><?supplied-pmid 32182899?><pub-id pub-id-type="pmid">32182899</pub-id></element-citation></ref><ref id="B38-ijms-22-03289"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>S.M.</given-names></name><name><surname>Park</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>S.H.</given-names></name><name><surname>Jung</surname><given-names>Y.K.</given-names></name></person-group><article-title>Emerging perspectives on mitochondrial dysfunction and inflammation in Alzheimer&#x02019;s disease</article-title><source>BMB Rep.</source><year>2020</year><volume>53</volume><fpage>35</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.5483/BMBRep.2020.53.1.274</pub-id><pub-id pub-id-type="pmid">31818363</pub-id></element-citation></ref><ref id="B39-ijms-22-03289"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santoni</surname><given-names>G.</given-names></name><name><surname>Cardinali</surname><given-names>C.</given-names></name><name><surname>Morelli</surname><given-names>M.B.</given-names></name><name><surname>Santoni</surname><given-names>M.</given-names></name><name><surname>Nabissi</surname><given-names>M.</given-names></name><name><surname>Amantini</surname><given-names>C.</given-names></name></person-group><article-title>Danger- and pathogen-associated molecular patterns recognition by pattern-recognition receptors and ion channels of the transient receptor potential family triggers the inflammasome activation in immune cells and sensory neurons</article-title><source>J. Neuroinflamm.</source><year>2015</year><volume>12</volume><fpage>21</fpage><pub-id pub-id-type="doi">10.1186/s12974-015-0239-2</pub-id></element-citation></ref><ref id="B40-ijms-22-03289"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Horssen</surname><given-names>J.</given-names></name><name><surname>van Schaik</surname><given-names>P.</given-names></name><name><surname>Witte</surname><given-names>M.</given-names></name></person-group><article-title>Inflammation and mitochondrial dysfunction: A vicious circle in neurodegenerative disorders?</article-title><source>Neurosci. Lett.</source><year>2019</year><volume>710</volume><fpage>132931</fpage><pub-id pub-id-type="doi">10.1016/j.neulet.2017.06.050</pub-id><pub-id pub-id-type="pmid">28668382</pub-id></element-citation></ref><ref id="B41-ijms-22-03289"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Joo</surname><given-names>D.</given-names></name><name><surname>Sun</surname><given-names>S.C.</given-names></name></person-group><article-title>NF-kB signaling in inflammation</article-title><source>Signal. Transduct. Target Ther.</source><year>2017</year><volume>2</volume><fpage>17023</fpage><pub-id pub-id-type="doi">10.1038/sigtrans.2017.23</pub-id><?supplied-pmid 29158945?><pub-id pub-id-type="pmid">29158945</pub-id></element-citation></ref><ref id="B42-ijms-22-03289"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hickman</surname><given-names>S.</given-names></name><name><surname>Izzy</surname><given-names>S.</given-names></name><name><surname>Sen</surname><given-names>P.</given-names></name><name><surname>Morsett</surname><given-names>L.</given-names></name><name><surname>El</surname><given-names>K.J.</given-names></name></person-group><article-title>Microglia in neurodegeneration</article-title><source>Nat. Neurosci.</source><year>2018</year><volume>21</volume><fpage>1359</fpage><lpage>1369</lpage><pub-id pub-id-type="doi">10.1038/s41593-018-0242-x</pub-id><pub-id pub-id-type="pmid">30258234</pub-id></element-citation></ref><ref id="B43-ijms-22-03289"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravari</surname><given-names>A.</given-names></name><name><surname>Mirzaei</surname><given-names>T.</given-names></name><name><surname>Kennedy</surname><given-names>D.</given-names></name><name><surname>Kazemi</surname><given-names>A.M.</given-names></name></person-group><article-title>Chronoinflammaging in Alzheimer; A systematic review on the roles of toll like receptor 2</article-title><source>Life Sci.</source><year>2017</year><volume>171</volume><fpage>16</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2017.01.003</pub-id><?supplied-pmid 28087373?><pub-id pub-id-type="pmid">28087373</pub-id></element-citation></ref><ref id="B44-ijms-22-03289"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>N.</given-names></name><name><surname>Youle</surname><given-names>R.J.</given-names></name><name><surname>Finkel</surname><given-names>T.</given-names></name></person-group><article-title>The mitochondrial basis of aging</article-title><source>Mol. Cell</source><year>2016</year><volume>61</volume><fpage>654</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2016.01.028</pub-id><pub-id pub-id-type="pmid">26942670</pub-id></element-citation></ref><ref id="B45-ijms-22-03289"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Missiroli</surname><given-names>S.</given-names></name><name><surname>Patergnani</surname><given-names>S.</given-names></name><name><surname>Caroccia</surname><given-names>N.</given-names></name><name><surname>Pedriali</surname><given-names>G.</given-names></name><name><surname>Perrone</surname><given-names>M.</given-names></name><name><surname>Previati</surname><given-names>M.</given-names></name><name><surname>Wieckowski</surname><given-names>M.R.</given-names></name><name><surname>Giorgi</surname><given-names>C.</given-names></name></person-group><article-title>Mitochondria-associated membranes (MAMs) and inflammation</article-title><source>Cell Death. Dis.</source><year>2018</year><volume>9</volume><fpage>329</fpage><pub-id pub-id-type="doi">10.1038/s41419-017-0027-2</pub-id><?supplied-pmid 29491386?><pub-id pub-id-type="pmid">29491386</pub-id></element-citation></ref><ref id="B46-ijms-22-03289"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>M.S.</given-names></name></person-group><article-title>CISD2 attenuates inflammation and regulates microglia polarization in EOC microglial cells-as a potential therapeutic target for neurodegenerative dementia</article-title><source>Front. Aging Neurosci.</source><year>2020</year><volume>12</volume><fpage>260</fpage><pub-id pub-id-type="doi">10.3389/fnagi.2020.00260</pub-id><pub-id pub-id-type="pmid">33005144</pub-id></element-citation></ref><ref id="B47-ijms-22-03289"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>G.</given-names></name><name><surname>Cheng</surname><given-names>L.</given-names></name><name><surname>Qin</surname><given-names>Q.</given-names></name><name><surname>Frontin</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>Q.</given-names></name></person-group><article-title>PPARdelta modulates lipopolysaccharide-induced TNFalpha inflammation signaling in cultured cardiomyocytes</article-title><source>J. Mol. Cell. Cardiol.</source><year>2006</year><volume>40</volume><fpage>821</fpage><lpage>828</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2006.03.422</pub-id><pub-id pub-id-type="pmid">16698033</pub-id></element-citation></ref><ref id="B48-ijms-22-03289"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galuppo</surname><given-names>M.</given-names></name><name><surname>Di</surname><given-names>P.R.</given-names></name><name><surname>Mazzon</surname><given-names>E.</given-names></name><name><surname>Esposito</surname><given-names>E.</given-names></name><name><surname>Paterniti</surname><given-names>I.</given-names></name><name><surname>Kapoor</surname><given-names>A.</given-names></name><name><surname>Thiemermann</surname><given-names>C.</given-names></name><name><surname>Cuzzocrea</surname><given-names>S.</given-names></name></person-group><article-title>GW0742, a high affinity PPAR-&#x003b2;/&#x003b4; agonist reduces lung inflammation induced by bleomycin instillation in mice</article-title><source>Int. J. Immunopathol. Pharmacol.</source><year>2010</year><volume>23</volume><fpage>1033</fpage><lpage>1046</lpage><pub-id pub-id-type="doi">10.1177/039463201002300408</pub-id><pub-id pub-id-type="pmid">21244753</pub-id></element-citation></ref><ref id="B49-ijms-22-03289"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreno-Navarrete</surname><given-names>J.M.</given-names></name><name><surname>Moreno</surname><given-names>M.</given-names></name><name><surname>Ortega</surname><given-names>F.</given-names></name><name><surname>Sabater</surname><given-names>M.</given-names></name><name><surname>Xifra</surname><given-names>G.</given-names></name><name><surname>Ricart</surname><given-names>W.</given-names></name><name><surname>Fern&#x000e1;ndez-Real</surname><given-names>J.M.</given-names></name></person-group><article-title>CISD1 in association with obesity-associated dysfunctional adipogenesis in human visceral adipose tissue</article-title><source>Obesity (Silver Spring)</source><year>2016</year><volume>24</volume><fpage>139</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1002/oby.21334</pub-id><pub-id pub-id-type="pmid">26692580</pub-id></element-citation></ref><ref id="B50-ijms-22-03289"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Baur</surname><given-names>J.A.</given-names></name></person-group><article-title>A NEET way to impair mitochondrial function in &#x003b1;- and &#x003b2;-cells</article-title><source>Diabetes</source><year>2016</year><volume>65</volume><fpage>1484</fpage><lpage>1486</lpage><pub-id pub-id-type="doi">10.2337/dbi16-0011</pub-id><pub-id pub-id-type="pmid">27222393</pub-id></element-citation></ref><ref id="B51-ijms-22-03289"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Lai</surname><given-names>S.</given-names></name><name><surname>Ye</surname><given-names>K.</given-names></name></person-group><article-title>Structure and molecular evolution of CDGSH iron-sulfur domains</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><elocation-id>e24790</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0024790</pub-id><?supplied-pmid 21949752?><pub-id pub-id-type="pmid">21949752</pub-id></element-citation></ref><ref id="B52-ijms-22-03289"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pesce</surname><given-names>L.</given-names></name><name><surname>Calandrini</surname><given-names>V.</given-names></name><name><surname>Marjault</surname><given-names>H.B.</given-names></name><name><surname>Lipper</surname><given-names>C.H.</given-names></name><name><surname>Rossetti</surname><given-names>G.</given-names></name><name><surname>Mittler</surname><given-names>R.</given-names></name><name><surname>Jennings</surname><given-names>P.A.</given-names></name><name><surname>Bauer</surname><given-names>A.</given-names></name><name><surname>Nechushtai</surname><given-names>R.</given-names></name><name><surname>Carloni</surname><given-names>P.</given-names></name></person-group><article-title>Molecular dynamics simulations of the [2Fe-2S] cluster-binding domain of NEET proteins reveal key molecular determinants that induce their cluster transfer/release</article-title><source>J. Phys. Chem. B</source><year>2017</year><volume>121</volume><fpage>10648</fpage><lpage>10656</lpage><pub-id pub-id-type="doi">10.1021/acs.jpcb.7b10584</pub-id><pub-id pub-id-type="pmid">29086562</pub-id></element-citation></ref><ref id="B53-ijms-22-03289"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kusminski</surname><given-names>C.M.</given-names></name><name><surname>Holland</surname><given-names>W.L.</given-names></name><name><surname>Sun</surname><given-names>K.</given-names></name><name><surname>Park</surname><given-names>J.</given-names></name><name><surname>Spurgin</surname><given-names>S.B.</given-names></name><name><surname>Lin</surname><given-names>Y.</given-names></name><name><surname>Askew</surname><given-names>G.R.</given-names></name><name><surname>Simcox</surname><given-names>J.A.</given-names></name><name><surname>McClain</surname><given-names>D.A.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><etal/></person-group><article-title>MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity</article-title><source>Nat. Med.</source><year>2012</year><volume>18</volume><fpage>1539</fpage><lpage>1549</lpage><pub-id pub-id-type="doi">10.1038/nm.2899</pub-id><pub-id pub-id-type="pmid">22961109</pub-id></element-citation></ref><ref id="B54-ijms-22-03289"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nechushtai</surname><given-names>R.</given-names></name><name><surname>Conlan</surname><given-names>A.R.</given-names></name><name><surname>Harir</surname><given-names>Y.</given-names></name><name><surname>Song</surname><given-names>L.</given-names></name><name><surname>Yogev</surname><given-names>O.</given-names></name><name><surname>Eisenberg-Domovich</surname><given-names>Y.</given-names></name><name><surname>Livnah</surname><given-names>O.</given-names></name><name><surname>Michaeli</surname><given-names>D.</given-names></name><name><surname>Rosen</surname><given-names>R.</given-names></name><name><surname>Ma</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Characterization of arabidopsis NEET reveals an ancient role for NEET proteins in iron metabolism</article-title><source>Plant Cell</source><year>2012</year><volume>24</volume><fpage>2139</fpage><lpage>2154</lpage><pub-id pub-id-type="doi">10.1105/tpc.112.097634</pub-id><pub-id pub-id-type="pmid">22562611</pub-id></element-citation></ref><ref id="B55-ijms-22-03289"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiley</surname><given-names>S.E.</given-names></name><name><surname>Andreyev</surname><given-names>A.Y.</given-names></name><name><surname>Divakaruni</surname><given-names>A.S.</given-names></name><name><surname>Karisch</surname><given-names>R.</given-names></name><name><surname>Perkins</surname><given-names>G.</given-names></name><name><surname>Wall</surname><given-names>E.A.</given-names></name><name><surname>van der</surname><given-names>G.P.</given-names></name><name><surname>Chen</surname><given-names>Y.F.</given-names></name><name><surname>Tsai</surname><given-names>T.F.</given-names></name><name><surname>Simon</surname><given-names>M.I.</given-names></name><etal/></person-group><article-title>Wolfram Syndrome protein, Miner1, regulates sulphydryl redox status, the unfolded protein response, and Ca2+ homeostasis</article-title><source>EMBO Mol. Med.</source><year>2013</year><volume>5</volume><fpage>904</fpage><lpage>918</lpage><pub-id pub-id-type="doi">10.1002/emmm.201201429</pub-id><pub-id pub-id-type="pmid">23703906</pub-id></element-citation></ref><ref id="B56-ijms-22-03289"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inupakutika</surname><given-names>M.A.</given-names></name><name><surname>Sengupta</surname><given-names>S.</given-names></name><name><surname>Nechushtai</surname><given-names>R.</given-names></name><name><surname>Jennings</surname><given-names>P.A.</given-names></name><name><surname>Onuchic</surname><given-names>J.N.</given-names></name><name><surname>Azad</surname><given-names>R.K.</given-names></name><name><surname>Padilla</surname><given-names>P.</given-names></name><name><surname>Mittler</surname><given-names>R.</given-names></name></person-group><article-title>Phylogenetic analysis of eukaryotic NEET proteins uncovers a link between a key gene duplication event and the evolution of vertebrates</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>42571</fpage><pub-id pub-id-type="doi">10.1038/srep42571</pub-id><pub-id pub-id-type="pmid">28205535</pub-id></element-citation></ref><ref id="B57-ijms-22-03289"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karmi</surname><given-names>O.</given-names></name><name><surname>Marjault</surname><given-names>H.B.</given-names></name><name><surname>Pesce</surname><given-names>L.</given-names></name><name><surname>Carloni</surname><given-names>P.</given-names></name><name><surname>Onuchic</surname><given-names>J.N.</given-names></name><name><surname>Jennings</surname><given-names>P.A.</given-names></name><name><surname>Mittler</surname><given-names>R.</given-names></name><name><surname>Nechushtai</surname><given-names>R.</given-names></name></person-group><article-title>The unique fold and lability of the [2Fe-2S] clusters of NEET proteins mediate their key functions in health and disease</article-title><source>J. Biol. Inorg. Chem.</source><year>2018</year><volume>23</volume><fpage>599</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1007/s00775-018-1538-8</pub-id><pub-id pub-id-type="pmid">29435647</pub-id></element-citation></ref><ref id="B58-ijms-22-03289"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amr</surname><given-names>S.</given-names></name><name><surname>Heisey</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Xia</surname><given-names>X.J.</given-names></name><name><surname>Shows</surname><given-names>K.H.</given-names></name><name><surname>Ajlouni</surname><given-names>K.</given-names></name><name><surname>Pandya</surname><given-names>A.</given-names></name><name><surname>Satin</surname><given-names>L.S.</given-names></name><name><surname>El-Shanti</surname><given-names>H.</given-names></name><name><surname>Shiang</surname><given-names>R.</given-names></name></person-group><article-title>A homozygous mutation in a novel zinc-finger protein, ERIS, is responsible for Wolfram syndrome 2</article-title><source>Am. J. Hum. Genet.</source><year>2007</year><volume>81</volume><fpage>673</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1086/520961</pub-id><pub-id pub-id-type="pmid">17846994</pub-id></element-citation></ref><ref id="B59-ijms-22-03289"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamir</surname><given-names>S.</given-names></name><name><surname>Paddock</surname><given-names>M.L.</given-names></name><name><surname>Rash-Yahana-Baram</surname><given-names>M.</given-names></name><name><surname>Holt</surname><given-names>S.H.</given-names></name><name><surname>Sohn</surname><given-names>Y.S.</given-names></name><name><surname>Agranat</surname><given-names>L.</given-names></name><name><surname>Michaeli</surname><given-names>D.</given-names></name><name><surname>Stofleth</surname><given-names>J.T.</given-names></name><name><surname>Lipper</surname><given-names>C.H.</given-names></name><name><surname>Morcos</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Structure-function analysis of NEET proteins uncovers their role as key regulators of iron and ROS homeostasis in health and disease</article-title><source>Biochim. Biophys. Acta</source><year>2015</year><volume>1853</volume><fpage>1294</fpage><lpage>1315</lpage><pub-id pub-id-type="doi">10.1016/j.bbamcr.2014.10.014</pub-id><?supplied-pmid 25448035?><pub-id pub-id-type="pmid">25448035</pub-id></element-citation></ref><ref id="B60-ijms-22-03289"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bak</surname><given-names>D.W.</given-names></name><name><surname>Elliott</surname><given-names>S.J.</given-names></name></person-group><article-title>Conserved hydrogen bonding networks of MitoNEET tune Fe-S cluster binding and structural stability</article-title><source>Biochemistry</source><year>2013</year><volume>52</volume><fpage>4687</fpage><lpage>4696</lpage><pub-id pub-id-type="doi">10.1021/bi400540m</pub-id><?supplied-pmid 23758282?><pub-id pub-id-type="pmid">23758282</pub-id></element-citation></ref><ref id="B61-ijms-22-03289"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lill</surname><given-names>R.</given-names></name></person-group><article-title>Function and biogenesis of iron-sulphur proteins</article-title><source>Nature</source><year>2009</year><volume>460</volume><fpage>831</fpage><lpage>838</lpage><pub-id pub-id-type="doi">10.1038/nature08301</pub-id><pub-id pub-id-type="pmid">19675643</pub-id></element-citation></ref><ref id="B62-ijms-22-03289"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golinelli-Cohen</surname><given-names>M.P.</given-names></name><name><surname>Lescop</surname><given-names>E.</given-names></name><name><surname>Mons</surname><given-names>C.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>S.</given-names></name><name><surname>Cl&#x000e9;mancey</surname><given-names>M.</given-names></name><name><surname>Santolini</surname><given-names>J.</given-names></name><name><surname>Guittet</surname><given-names>E.</given-names></name><name><surname>Blondin</surname><given-names>G.</given-names></name><name><surname>Latour</surname><given-names>J.M.</given-names></name><name><surname>Bouton</surname><given-names>C.</given-names></name></person-group><article-title>Redox control of the human iron-sulfur repair protein MitoNEET activity via its iron-sulfur cluster</article-title><source>J. Biol. Chem.</source><year>2016</year><volume>291</volume><fpage>7583</fpage><lpage>7593</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.711218</pub-id><pub-id pub-id-type="pmid">26887944</pub-id></element-citation></ref><ref id="B63-ijms-22-03289"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>G.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Pan</surname><given-names>F.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Shen</surname><given-names>B.</given-names></name><name><surname>Lyu</surname><given-names>J.</given-names></name></person-group><article-title>His-87 ligand in mitoNEET is crucial for the transfer of iron sulfur clusters from mitochondria to cytosolic aconitase</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2016</year><volume>470</volume><fpage>226</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2016.01.040</pub-id><?supplied-pmid 26778000?><pub-id pub-id-type="pmid">26778000</pub-id></element-citation></ref><ref id="B64-ijms-22-03289"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuris</surname><given-names>J.A.</given-names></name><name><surname>Harir</surname><given-names>Y.</given-names></name><name><surname>Conlan</surname><given-names>A.R.</given-names></name><name><surname>Shvartsman</surname><given-names>M.</given-names></name><name><surname>Michaeli</surname><given-names>D.</given-names></name><name><surname>Tamir</surname><given-names>S.</given-names></name><name><surname>Paddock</surname><given-names>M.L.</given-names></name><name><surname>Onuchic</surname><given-names>J.N.</given-names></name><name><surname>Mittler</surname><given-names>R.</given-names></name><name><surname>Cabantchik</surname><given-names>Z.I.</given-names></name><etal/></person-group><article-title>Facile transfer of [2Fe-2S] clusters from the diabetes drug target mitoNEET to an apo-acceptor protein</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2011</year><volume>108</volume><fpage>13047</fpage><lpage>13052</lpage><pub-id pub-id-type="doi">10.1073/pnas.1109986108</pub-id><?supplied-pmid 21788481?><pub-id pub-id-type="pmid">21788481</pub-id></element-citation></ref><ref id="B65-ijms-22-03289"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nobili</surname><given-names>A.</given-names></name><name><surname>Krashia</surname><given-names>P.</given-names></name><name><surname>D&#x02019;Amelio</surname><given-names>M.</given-names></name></person-group><article-title>Cisd2: A promising new target in Alzheimer&#x02019;s disease</article-title><source>J. Pathol.</source><year>2020</year><volume>251</volume><fpage>113</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1002/path.5436</pub-id><?supplied-pmid 32207855?><pub-id pub-id-type="pmid">32207855</pub-id></element-citation></ref><ref id="B66-ijms-22-03289"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.H.</given-names></name><name><surname>Chen</surname><given-names>Y.F.</given-names></name><name><surname>Wu</surname><given-names>C.Y.</given-names></name><name><surname>Wu</surname><given-names>P.C.</given-names></name><name><surname>Huang</surname><given-names>Y.L.</given-names></name><name><surname>Kao</surname><given-names>C.H.</given-names></name><name><surname>Lin</surname><given-names>C.H.</given-names></name><name><surname>Kao</surname><given-names>L.S.</given-names></name><name><surname>Tsai</surname><given-names>T.F.</given-names></name><name><surname>Wei</surname><given-names>Y.H.</given-names></name></person-group><article-title>Cisd2 modulates the differentiation and functioning of adipocytes by regulating intracellular Ca2+ homeostasis</article-title><source>Hum. Mol. Genet.</source><year>2014</year><volume>23</volume><fpage>4770</fpage><lpage>4785</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddu193</pub-id><pub-id pub-id-type="pmid">24833725</pub-id></element-citation></ref><ref id="B67-ijms-22-03289"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>N.C.</given-names></name><name><surname>Nguyen</surname><given-names>M.</given-names></name><name><surname>Shore</surname><given-names>G.C.</given-names></name></person-group><article-title>BCL2-CISD2: An ER complex at the nexus of autophagy and calcium homeostasis?</article-title><source>Autophagy</source><year>2012</year><volume>8</volume><fpage>856</fpage><lpage>857</lpage><pub-id pub-id-type="doi">10.4161/auto.20054</pub-id><pub-id pub-id-type="pmid">22617439</pub-id></element-citation></ref><ref id="B68-ijms-22-03289"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>N.C.</given-names></name><name><surname>Nguyen</surname><given-names>M.</given-names></name><name><surname>Bourdon</surname><given-names>J.</given-names></name><name><surname>Risse</surname><given-names>P.A.</given-names></name><name><surname>Martin</surname><given-names>J.</given-names></name><name><surname>Danialou</surname><given-names>G.</given-names></name><name><surname>Rizzuto</surname><given-names>R.</given-names></name><name><surname>Petrof</surname><given-names>B.J.</given-names></name><name><surname>Shore</surname><given-names>G.C.</given-names></name></person-group><article-title>Bcl-2-associated autophagy regulator Naf-1 required for maintenance of skeletal muscle</article-title><source>Hum. Mol. Genet.</source><year>2012</year><volume>21</volume><fpage>2277</fpage><lpage>2287</lpage><pub-id pub-id-type="doi">10.1093/hmg/dds048</pub-id><pub-id pub-id-type="pmid">22343142</pub-id></element-citation></ref><ref id="B69-ijms-22-03289"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>N.C.</given-names></name><name><surname>Nguyen</surname><given-names>M.</given-names></name><name><surname>Germain</surname><given-names>M.</given-names></name><name><surname>Shore</surname><given-names>G.C.</given-names></name></person-group><article-title>Antagonism of Beclin 1-dependent autophagy by BCL-2 at the endoplasmic reticulum requires NAF-1</article-title><source>EMBO J.</source><year>2010</year><volume>29</volume><fpage>606</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.1038/emboj.2009.369</pub-id><pub-id pub-id-type="pmid">20010695</pub-id></element-citation></ref><ref id="B70-ijms-22-03289"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>R.</given-names></name><name><surname>Zeh</surname><given-names>H.J.</given-names></name><name><surname>Lotze</surname><given-names>M.T.</given-names></name><name><surname>Tang</surname><given-names>D.</given-names></name></person-group><article-title>The Beclin 1 network regulates autophagy and apoptosis</article-title><source>Cell Death. Differ.</source><year>2011</year><volume>18</volume><fpage>571</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1038/cdd.2010.191</pub-id><pub-id pub-id-type="pmid">21311563</pub-id></element-citation></ref><ref id="B71-ijms-22-03289"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.F.</given-names></name><name><surname>Kao</surname><given-names>C.H.</given-names></name><name><surname>Chen</surname><given-names>Y.T.</given-names></name><name><surname>Wang</surname><given-names>C.H.</given-names></name><name><surname>Wu</surname><given-names>C.Y.</given-names></name><name><surname>Tsai</surname><given-names>C.Y.</given-names></name><name><surname>Liu</surname><given-names>F.C.</given-names></name><name><surname>Yang</surname><given-names>C.W.</given-names></name><name><surname>Wei</surname><given-names>Y.H.</given-names></name><name><surname>Hsu</surname><given-names>M.T.</given-names></name><etal/></person-group><article-title>Cisd2 deficiency drives premature aging and causes mitochondria-mediated defects in mice</article-title><source>Genes Dev.</source><year>2009</year><volume>23</volume><fpage>1183</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.1101/gad.1779509</pub-id><pub-id pub-id-type="pmid">19451219</pub-id></element-citation></ref><ref id="B72-ijms-22-03289"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rouzier</surname><given-names>C.</given-names></name><name><surname>Moore</surname><given-names>D.</given-names></name><name><surname>Delorme</surname><given-names>C.</given-names></name><name><surname>Lacas-Gervais</surname><given-names>S.</given-names></name><name><surname>it-El-Mkadem</surname><given-names>S.</given-names></name><name><surname>Fragaki</surname><given-names>K.</given-names></name><name><surname>Burte</surname><given-names>F.</given-names></name><name><surname>Serre</surname><given-names>V.</given-names></name><name><surname>Bannwarth</surname><given-names>S.</given-names></name><name><surname>Chaussenot</surname><given-names>A.</given-names></name><etal/></person-group><article-title>A novel CISD2 mutation associated with a classical Wolfram syndrome phenotype alters Ca2+ homeostasis and ER-mitochondria interactions</article-title><source>Hum. Mol. Genet.</source><year>2017</year><volume>26</volume><fpage>1599</fpage><lpage>1611</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddx060</pub-id><?supplied-pmid 28335035?><pub-id pub-id-type="pmid">28335035</pub-id></element-citation></ref><ref id="B73-ijms-22-03289"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>C.Y.</given-names></name><name><surname>Chen</surname><given-names>Y.F.</given-names></name><name><surname>Wang</surname><given-names>C.H.</given-names></name><name><surname>Kao</surname><given-names>C.H.</given-names></name><name><surname>Zhuang</surname><given-names>H.W.</given-names></name><name><surname>Chen</surname><given-names>C.C.</given-names></name><name><surname>Chen</surname><given-names>L.K.</given-names></name><name><surname>Kirby</surname><given-names>R.</given-names></name><name><surname>Wei</surname><given-names>Y.H.</given-names></name><name><surname>Tsai</surname><given-names>S.F.</given-names></name><etal/></person-group><article-title>A persistent level of Cisd2 extends healthy lifespan and delays aging in mice</article-title><source>Hum. Mol. Genet.</source><year>2012</year><volume>21</volume><fpage>3956</fpage><lpage>3968</lpage><pub-id pub-id-type="doi">10.1093/hmg/dds210</pub-id><?supplied-pmid 22661501?><pub-id pub-id-type="pmid">22661501</pub-id></element-citation></ref><ref id="B74-ijms-22-03289"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>S.J.</given-names></name><name><surname>Ng</surname><given-names>L.T.</given-names></name></person-group><article-title>Antioxidant and free radical scavenging activities of wild bitter melon (<italic>Momordica charantia</italic> Linn. var. abbreviata Ser.) in Taiwan</article-title><source>LWT</source><year>2008</year><volume>41</volume><fpage>323</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1016/j.lwt.2007.03.003</pub-id></element-citation></ref><ref id="B75-ijms-22-03289"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fauziah</surname><given-names>R.R.</given-names></name><name><surname>Ogita</surname><given-names>S.</given-names></name><name><surname>Yoshino</surname><given-names>T.</given-names></name><name><surname>Yamamoto</surname><given-names>Y.</given-names></name></person-group><article-title>Effect of molecular form of conjugated linoleic acid on oxidative stability: Comparison of triacylglycerol and phosphatidylcholine form</article-title><source>J. Oleo. Sci.</source><year>2020</year><volume>69</volume><fpage>801</fpage><lpage>807</lpage><pub-id pub-id-type="doi">10.5650/jos.ess20028</pub-id><?supplied-pmid 32641609?><pub-id pub-id-type="pmid">32641609</pub-id></element-citation></ref><ref id="B76-ijms-22-03289"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>Q.</given-names></name><name><surname>Betancor</surname><given-names>M.B.</given-names></name><name><surname>Tocher</surname><given-names>D.R.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Yuan</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>T.</given-names></name><name><surname>Jiao</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Dietary soybean oil aggravates the adverse effects of low salinity on intestinal health in juvenile mud crab Scylla paramamosain</article-title><source>Ecotoxicol. Environ. Saf.</source><year>2021</year><volume>213</volume><fpage>112004</fpage><pub-id pub-id-type="doi">10.1016/j.ecoenv.2021.112004</pub-id><?supplied-pmid 33581488?><pub-id pub-id-type="pmid">33581488</pub-id></element-citation></ref><ref id="B77-ijms-22-03289"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abedi</surname><given-names>E.</given-names></name><name><surname>Sahari</surname><given-names>M.A.</given-names></name></person-group><article-title>Long-chain polyunsaturated fatty acid sources and evaluation of their nutritional and functional properties</article-title><source>Food Sci. Nutr.</source><year>2014</year><volume>2</volume><fpage>443</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1002/fsn3.121</pub-id><pub-id pub-id-type="pmid">25473503</pub-id></element-citation></ref><ref id="B78-ijms-22-03289"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basiric&#x000f2;</surname><given-names>L.</given-names></name><name><surname>Morera</surname><given-names>P.</given-names></name><name><surname>Dipasquale</surname><given-names>D.</given-names></name><name><surname>Tr&#x000f6;scher</surname><given-names>A.</given-names></name><name><surname>Bernabucci</surname><given-names>U.</given-names></name></person-group><article-title>Comparison between conjugated linoleic acid and essential fatty acids in preventing oxidative stress in bovine mammary epithelial cells</article-title><source>J. Dairy Sci.</source><year>2017</year><volume>100</volume><fpage>2299</fpage><lpage>2309</lpage><pub-id pub-id-type="doi">10.3168/jds.2016-11729</pub-id><pub-id pub-id-type="pmid">28088424</pub-id></element-citation></ref><ref id="B79-ijms-22-03289"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montecillo-Aguado</surname><given-names>M.</given-names></name><name><surname>Tirado-Rodriguez</surname><given-names>B.</given-names></name><name><surname>Tong</surname><given-names>Z.</given-names></name><name><surname>Vega</surname><given-names>O.M.</given-names></name><name><surname>Morales-Mart&#x000ed;nez</surname><given-names>M.</given-names></name><name><surname>Abkenari</surname><given-names>S.</given-names></name><name><surname>Pedraza-Chaverri</surname><given-names>J.</given-names></name><name><surname>Huerta-Yepez</surname><given-names>S.</given-names></name></person-group><article-title>Importance of the role of &#x003c9;-3 and &#x003c9;-6 polyunsaturated fatty acids in the progression of brain cancer</article-title><source>Brain Sci.</source><year>2020</year><volume>10</volume><elocation-id>381</elocation-id><pub-id pub-id-type="doi">10.3390/brainsci10060381</pub-id></element-citation></ref><ref id="B80-ijms-22-03289"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>Y.</given-names></name></person-group><article-title>Immuno-resolving ability of resolvins, protectins, and maresins derived from omega-3 fatty acids in metabolic syndrome</article-title><source>Mol. Nutr. Food Res.</source><year>2020</year><volume>64</volume><fpage>e1900824</fpage><pub-id pub-id-type="doi">10.1002/mnfr.201900824</pub-id><pub-id pub-id-type="pmid">31797565</pub-id></element-citation></ref><ref id="B81-ijms-22-03289"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname><given-names>E.</given-names></name><name><surname>Wall</surname><given-names>R.</given-names></name><name><surname>Fitzgerald</surname><given-names>G.F.</given-names></name><name><surname>Ross</surname><given-names>R.P.</given-names></name><name><surname>Stanton</surname><given-names>C.</given-names></name></person-group><article-title>Health implications of high dietary omega-6 polyunsaturated fatty acids</article-title><source>J. Nutr. Metab.</source><year>2012</year><volume>2012</volume><fpage>539426</fpage><pub-id pub-id-type="doi">10.1155/2012/539426</pub-id><pub-id pub-id-type="pmid">22570770</pub-id></element-citation></ref><ref id="B82-ijms-22-03289"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saha</surname><given-names>S.S.</given-names></name><name><surname>Ghosh</surname><given-names>M.</given-names></name></person-group><article-title>Antioxidant and anti-inflammatory effect of conjugated linolenic acid isomers against streptozotocin-induced diabetes</article-title><source>Br. J. Nutr.</source><year>2012</year><volume>108</volume><fpage>974</fpage><lpage>983</lpage><pub-id pub-id-type="doi">10.1017/S0007114511006325</pub-id><pub-id pub-id-type="pmid">22182422</pub-id></element-citation></ref><ref id="B83-ijms-22-03289"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aila</surname><given-names>G.</given-names></name><name><surname>Catozzi</surname><given-names>C.</given-names></name><name><surname>Pravettoni</surname><given-names>D.</given-names></name><name><surname>Sala</surname><given-names>G.</given-names></name><name><surname>Martino</surname><given-names>P.</given-names></name><name><surname>Meroni</surname><given-names>G.</given-names></name><name><surname>Lecchi</surname><given-names>C.</given-names></name><name><surname>Ceciliani</surname><given-names>F.</given-names></name></person-group><article-title>In vitro effects of conjugated linoleic acid (CLA) on inflammatory functions of bovine monocytes</article-title><source>J. Dairy Sci.</source><year>2020</year><volume>103</volume><fpage>8554</fpage><lpage>8563</lpage><pub-id pub-id-type="doi">10.3168/jds.2020-18659</pub-id><pub-id pub-id-type="pmid">32684447</pub-id></element-citation></ref><ref id="B84-ijms-22-03289"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuzuki</surname><given-names>T.</given-names></name><name><surname>Tokuyama</surname><given-names>Y.</given-names></name><name><surname>Igarashi</surname><given-names>M.</given-names></name><name><surname>Miyazawa</surname><given-names>T.</given-names></name></person-group><article-title>Tumor growth suppression by alpha-eleostearic acid, a linolenic acid isomer with a conjugated triene system, via lipid peroxidation</article-title><source>Carcinogenesis</source><year>2004</year><volume>25</volume><fpage>1417</fpage><lpage>1425</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgh109</pub-id><pub-id pub-id-type="pmid">14963014</pub-id></element-citation></ref><ref id="B85-ijms-22-03289"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhar Dubey</surname><given-names>K.K.</given-names></name><name><surname>Sharma</surname><given-names>G.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name></person-group><article-title>Conjugated linolenic acids: Implication in cancer</article-title><source>J. Agric. Food Chem.</source><year>2019</year><volume>67</volume><fpage>6091</fpage><lpage>6101</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.9b01379</pub-id><?supplied-pmid 31070027?><pub-id pub-id-type="pmid">31070027</pub-id></element-citation></ref><ref id="B86-ijms-22-03289"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmid</surname><given-names>A.</given-names></name><name><surname>Collomb</surname><given-names>M.</given-names></name><name><surname>Sieber</surname><given-names>R.</given-names></name><name><surname>Bee</surname><given-names>G.</given-names></name></person-group><article-title>Conjugated linoleic acid in meat and meat products: A review</article-title><source>Meat. Sci.</source><year>2006</year><volume>73</volume><fpage>29</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.meatsci.2005.10.010</pub-id><?supplied-pmid 22062051?><pub-id pub-id-type="pmid">22062051</pub-id></element-citation></ref><ref id="B87-ijms-22-03289"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuzuki</surname><given-names>T.</given-names></name><name><surname>Tokuyama</surname><given-names>Y.</given-names></name><name><surname>Igarashi</surname><given-names>M.</given-names></name><name><surname>Nakagawa</surname><given-names>K.</given-names></name><name><surname>Ohsaki</surname><given-names>Y.</given-names></name><name><surname>Komai</surname><given-names>M.</given-names></name><name><surname>Miyazawa</surname><given-names>T.</given-names></name></person-group><article-title>Alpha-eleostearic acid (9Z11E13E-18:3) is quickly converted to conjugated linoleic acid (9Z11E-18:2) in rats</article-title><source>J. Nutr.</source><year>2004</year><volume>134</volume><fpage>2634</fpage><lpage>2639</lpage><pub-id pub-id-type="doi">10.1093/jn/134.10.2634</pub-id><?supplied-pmid 15465759?><pub-id pub-id-type="pmid">15465759</pub-id></element-citation></ref><ref id="B88-ijms-22-03289"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwata</surname><given-names>T.</given-names></name><name><surname>Kamegai</surname><given-names>T.</given-names></name><name><surname>Yamauchi-Sato</surname><given-names>Y.</given-names></name><name><surname>Ogawa</surname><given-names>A.</given-names></name><name><surname>Kasai</surname><given-names>M.</given-names></name><name><surname>Aoyama</surname><given-names>T.</given-names></name><name><surname>Kondo</surname><given-names>K.</given-names></name></person-group><article-title>Safety of dietary conjugated linoleic acid (CLA) in a 12-weeks trial in healthy overweight Japanese male volunteers</article-title><source>J. Oleo. Sci.</source><year>2007</year><volume>56</volume><fpage>517</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.5650/jos.56.517</pub-id><?supplied-pmid 17898458?><pub-id pub-id-type="pmid">17898458</pub-id></element-citation></ref><ref id="B89-ijms-22-03289"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arao</surname><given-names>K.</given-names></name><name><surname>Yotsumoto</surname><given-names>H.</given-names></name><name><surname>Han</surname><given-names>S.Y.</given-names></name><name><surname>Nagao</surname><given-names>K.</given-names></name><name><surname>Yanagita</surname><given-names>T.</given-names></name></person-group><article-title>The 9cis,11trans,13cis isomer of conjugated linolenic acid reduces apolipoprotein B100 secretion and triacylglycerol synthesis in HepG2 cells</article-title><source>Biosci. Biotechnol. Biochem.</source><year>2004</year><volume>68</volume><fpage>2643</fpage><lpage>2645</lpage><pub-id pub-id-type="doi">10.1271/bbb.68.2643</pub-id><pub-id pub-id-type="pmid">15618643</pub-id></element-citation></ref><ref id="B90-ijms-22-03289"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hennessy</surname><given-names>A.A.</given-names></name><name><surname>Ross</surname><given-names>P.R.</given-names></name><name><surname>Fitzgerald</surname><given-names>G.F.</given-names></name><name><surname>Stanton</surname><given-names>C.</given-names></name></person-group><article-title>Sources and bioactive properties of conjugated dietary fatty acids</article-title><source>Lipids</source><year>2016</year><volume>51</volume><fpage>377</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1007/s11745-016-4135-z</pub-id><?supplied-pmid 26968402?><pub-id pub-id-type="pmid">26968402</pub-id></element-citation></ref><ref id="B91-ijms-22-03289"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhar</surname><given-names>P.</given-names></name><name><surname>Bhattacharyya</surname><given-names>D.</given-names></name><name><surname>Bhattacharyya</surname><given-names>D.K.</given-names></name><name><surname>Ghosh</surname><given-names>S.</given-names></name></person-group><article-title>Dietary comparison of conjugated linolenic acid (9 cis, 11 trans, 13 trans) and alpha-tocopherol effects on blood lipids and lipid peroxidation in alloxan-induced diabetes mellitus in rats</article-title><source>Lipids</source><year>2006</year><volume>41</volume><fpage>49</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1007/s11745-006-5069-7</pub-id><pub-id pub-id-type="pmid">16555471</pub-id></element-citation></ref><ref id="B92-ijms-22-03289"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhar</surname><given-names>P.</given-names></name><name><surname>Ghosh</surname><given-names>S.</given-names></name><name><surname>Bhattacharyya</surname><given-names>D.K.</given-names></name></person-group><article-title>Dietary effects of conjugated octadecatrienoic fatty acid (9 cis, 11 trans, 13 trans) levels on blood lipids and nonenzymatic in vitro lipid peroxidation in rats</article-title><source>Lipids</source><year>1999</year><volume>34</volume><fpage>109</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1007/s11745-999-0343-2</pub-id><pub-id pub-id-type="pmid">10102236</pub-id></element-citation></ref><ref id="B93-ijms-22-03289"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>G.F.</given-names></name><name><surname>Sinclair</surname><given-names>A.J.</given-names></name><name><surname>Zhou</surname><given-names>C.Q.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name></person-group><article-title>&#x003b1;-Eleostearic acid is more effectively metabolized into conjugated linoleic acid than punicic acid in mice</article-title><source>J. Sci. Food Agric.</source><year>2009</year><volume>89</volume><fpage>1006</fpage><lpage>1011</lpage><pub-id pub-id-type="doi">10.1002/jsfa.3547</pub-id></element-citation></ref><ref id="B94-ijms-22-03289"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuzuki</surname><given-names>T.</given-names></name><name><surname>Igarashi</surname><given-names>M.</given-names></name><name><surname>Komai</surname><given-names>M.</given-names></name><name><surname>Miyazawa</surname><given-names>T.</given-names></name></person-group><article-title>The metabolic conversion of 9,11,13-eleostearic acid (18:3) to 9,11-conjugated linoleic acid (18:2) in the rat</article-title><source>J. Nutr. Sci. Vitaminol. (Tokyo)</source><year>2003</year><volume>49</volume><fpage>195</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.3177/jnsv.49.195</pub-id><pub-id pub-id-type="pmid">12953798</pub-id></element-citation></ref><ref id="B95-ijms-22-03289"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>A.C.</given-names></name><name><surname>Mignolet</surname><given-names>E.</given-names></name><name><surname>Schneider</surname><given-names>Y.J.</given-names></name><name><surname>Larondelle</surname><given-names>Y.</given-names></name></person-group><article-title>Uptake of conjugated linolenic acids and conversion to cis-9, trans-11-or trans-9, trans-11-conjugated linoleic acids in Caco-2 cells</article-title><source>Br. J. Nutr.</source><year>2013</year><volume>109</volume><fpage>57</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1017/S0007114512000608</pub-id><pub-id pub-id-type="pmid">22472138</pub-id></element-citation></ref><ref id="B96-ijms-22-03289"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontes</surname><given-names>A.L.</given-names></name><name><surname>Pimentel</surname><given-names>L.</given-names></name><name><surname>Rodr&#x000ed;guez-Alcal&#x000e1;</surname><given-names>L.M.</given-names></name><name><surname>Gomes</surname><given-names>A.</given-names></name></person-group><article-title>Effect of pufa substrates on fatty acid profile of bifidobacterium breve Ncimb 702258 and CLA/CLNA production in commercial semi-skimmed milk</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>15591</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-33970-2</pub-id><?supplied-pmid 30349012?><pub-id pub-id-type="pmid">30349012</pub-id></element-citation></ref><ref id="B97-ijms-22-03289"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehnen</surname><given-names>T.E.</given-names></name><name><surname>da Silva</surname><given-names>M.R.</given-names></name><name><surname>Camacho</surname><given-names>A.</given-names></name><name><surname>Marcadenti</surname><given-names>A.</given-names></name><name><surname>Lehnen</surname><given-names>A.M.</given-names></name></person-group><article-title>A review on effects of conjugated linoleic fatty acid (CLA) upon body composition and energetic metabolism</article-title><source>J. Int. Soc. Sports Nutr.</source><year>2015</year><volume>12</volume><fpage>36</fpage><pub-id pub-id-type="doi">10.1186/s12970-015-0097-4</pub-id><pub-id pub-id-type="pmid">26388708</pub-id></element-citation></ref><ref id="B98-ijms-22-03289"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinohara</surname><given-names>N.</given-names></name><name><surname>Tsuduki</surname><given-names>T.</given-names></name><name><surname>Ito</surname><given-names>J.</given-names></name><name><surname>Honma</surname><given-names>T.</given-names></name><name><surname>Kijima</surname><given-names>R.</given-names></name><name><surname>Sugawara</surname><given-names>S.</given-names></name><name><surname>Arai</surname><given-names>T.</given-names></name><name><surname>Yamasaki</surname><given-names>M.</given-names></name><name><surname>Ikezaki</surname><given-names>A.</given-names></name><name><surname>Yokoyama</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Jacaric acid, a linolenic acid isomer with a conjugated triene system, has a strong antitumor effect in vitro and in vivo</article-title><source>Biochim. Biophys. Acta</source><year>2012</year><volume>1821</volume><fpage>980</fpage><lpage>988</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2012.04.001</pub-id><?supplied-pmid 22521763?><pub-id pub-id-type="pmid">22521763</pub-id></element-citation></ref><ref id="B99-ijms-22-03289"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chokki</surname><given-names>M.</given-names></name><name><surname>Cud&#x00103;lbeanu</surname><given-names>M.</given-names></name><name><surname>Zongo</surname><given-names>C.</given-names></name><name><surname>Dah-Nouvlessounon</surname><given-names>D.</given-names></name><name><surname>Ghinea</surname><given-names>I.O.</given-names></name><name><surname>Furdui</surname><given-names>B.</given-names></name><name><surname>Raclea</surname><given-names>R.</given-names></name><name><surname>Savadogo</surname><given-names>A.</given-names></name><name><surname>Baba-Moussa</surname><given-names>L.</given-names></name><name><surname>Avamescu</surname><given-names>S.M.</given-names></name><etal/></person-group><article-title>Exploring antioxidant and enzymes (A-Amylase and B-Glucosidase) inhibitory activity of morinda lucida and <italic>Momordica charantia</italic> leaves from benin</article-title><source>Foods</source><year>2020</year><volume>9</volume><elocation-id>434</elocation-id><pub-id pub-id-type="doi">10.3390/foods9040434</pub-id></element-citation></ref><ref id="B100-ijms-22-03289"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pham TM</surname><given-names>H.</given-names></name><name><surname>Ngo</surname><given-names>D.H.</given-names></name><name><surname>Ngo</surname><given-names>D.N.</given-names></name><name><surname>Vo</surname><given-names>T.S.</given-names></name></person-group><article-title>Investigation of biological activities of wild bitter melon (<italic>Momordica charantia</italic> Linn. Var. Abbreviata Ser.)</article-title><source>Biomolecules</source><year>2019</year><volume>9</volume><elocation-id>211</elocation-id><pub-id pub-id-type="doi">10.3390/biom9060211</pub-id></element-citation></ref><ref id="B101-ijms-22-03289"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bortolotti</surname><given-names>M.</given-names></name><name><surname>Mercatelli</surname><given-names>D.</given-names></name><name><surname>Polito</surname><given-names>L.</given-names></name></person-group><article-title>Momordica charantia, a nutraceutical approach for inflammatory related diseases</article-title><source>Front. Pharmacol.</source><year>2019</year><volume>10</volume><fpage>486</fpage><pub-id pub-id-type="doi">10.3389/fphar.2019.00486</pub-id><?supplied-pmid 31139079?><pub-id pub-id-type="pmid">31139079</pub-id></element-citation></ref><ref id="B102-ijms-22-03289"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y.S.</given-names></name><name><surname>Huang</surname><given-names>W.Y.</given-names></name><name><surname>Ho</surname><given-names>P.Y.</given-names></name><name><surname>Hu</surname><given-names>S.Y.</given-names></name><name><surname>Lin</surname><given-names>Y.Y.</given-names></name><name><surname>Chen</surname><given-names>C.Y.</given-names></name><name><surname>Chang</surname><given-names>M.Y.</given-names></name><name><surname>Huang</surname><given-names>S.L.</given-names></name></person-group><article-title>Effects of storage time and temperature on antioxidants in juice from <italic>Momordica charantia</italic> L. and <italic>Momordica charantia</italic> L. var</article-title><source>abbreviata Ser. Molecules</source><year>2020</year><volume>25</volume><elocation-id>3614</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25163614</pub-id><?supplied-pmid 32784816?><pub-id pub-id-type="pmid">32784816</pub-id></element-citation></ref><ref id="B103-ijms-22-03289"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>C.</given-names></name><name><surname>Hsieh</surname><given-names>C.L.</given-names></name><name><surname>Kuo</surname><given-names>Y.H.</given-names></name><name><surname>Huang</surname><given-names>C.J.</given-names></name></person-group><article-title>Isolation and identification of cucurbitane-type triterpenoids with partial agonist/antagonist potential for estrogen receptors from Momordica charantia</article-title><source>J. Agric. Food Chem.</source><year>2011</year><volume>59</volume><fpage>4553</fpage><lpage>4561</lpage><pub-id pub-id-type="doi">10.1021/jf200418g</pub-id><?supplied-pmid 21456596?><pub-id pub-id-type="pmid">21456596</pub-id></element-citation></ref><ref id="B104-ijms-22-03289"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobori</surname><given-names>M.</given-names></name><name><surname>Nakayama</surname><given-names>H.</given-names></name><name><surname>Fukushima</surname><given-names>K.</given-names></name><name><surname>Ohnishi-Kameyama</surname><given-names>M.</given-names></name><name><surname>Ono</surname><given-names>H.</given-names></name><name><surname>Fukushima</surname><given-names>T.</given-names></name><name><surname>Akimoto</surname><given-names>Y.</given-names></name><name><surname>Masumoto</surname><given-names>S.</given-names></name><name><surname>Yukizaki</surname><given-names>C.</given-names></name><name><surname>Hoshi</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Bitter gourd suppresses lipopolysaccharide-induced inflammatory responses</article-title><source>J. Agric. Food Chem.</source><year>2008</year><volume>56</volume><fpage>4004</fpage><lpage>4011</lpage><pub-id pub-id-type="doi">10.1021/jf800052y</pub-id><pub-id pub-id-type="pmid">18489106</pub-id></element-citation></ref><ref id="B105-ijms-22-03289"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krawinkel</surname><given-names>M.B.</given-names></name><name><surname>Keding</surname><given-names>G.B.</given-names></name></person-group><article-title>Bitter gourd (<italic>Momordica charantia</italic>): A dietary approach to hyperglycemia</article-title><source>Nutr. Rev.</source><year>2006</year><volume>64</volume><fpage>331</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1111/j.1753-4887.2006.tb00217.x</pub-id><pub-id pub-id-type="pmid">16910221</pub-id></element-citation></ref><ref id="B106-ijms-22-03289"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>C.H.</given-names></name><name><surname>Chen</surname><given-names>E.C.</given-names></name><name><surname>Tsay</surname><given-names>H.S.</given-names></name><name><surname>Huang</surname><given-names>C.J.</given-names></name></person-group><article-title>Wild bitter gourd improves metabolic syndrome: A preliminary dietary supplementation trial</article-title><source>Nutr. J.</source><year>2012</year><volume>11</volume><fpage>4</fpage><pub-id pub-id-type="doi">10.1186/1475-2891-11-4</pub-id><?supplied-pmid 22243626?><pub-id pub-id-type="pmid">22243626</pub-id></element-citation></ref><ref id="B107-ijms-22-03289"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>K.H.</given-names></name><name><surname>Tseng</surname><given-names>H.C.</given-names></name><name><surname>Liu</surname><given-names>C.T.</given-names></name><name><surname>Huang</surname><given-names>C.J.</given-names></name><name><surname>Chyuan</surname><given-names>J.H.</given-names></name><name><surname>Sheen</surname><given-names>L.Y.</given-names></name></person-group><article-title>Wild bitter gourd protects against alcoholic fatty liver in mice by attenuating oxidative stress and inflammatory responses</article-title><source>Food Funct.</source><year>2014</year><volume>5</volume><fpage>1027</fpage><lpage>1037</lpage><pub-id pub-id-type="doi">10.1039/C3FO60449G</pub-id><?supplied-pmid 24664243?><pub-id pub-id-type="pmid">24664243</pub-id></element-citation></ref><ref id="B108-ijms-22-03289"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>C.Y.</given-names></name><name><surname>Yin</surname><given-names>M.C.</given-names></name><name><surname>Huang</surname><given-names>C.J.</given-names></name></person-group><article-title>Wild bitter gourd extract up-regulates mRNA expression of PPARalpha, PPARgamma and their target genes in C57BL/6J mice</article-title><source>J. Ethnopharmacol.</source><year>2011</year><volume>135</volume><fpage>156</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2011.03.001</pub-id><pub-id pub-id-type="pmid">21392566</pub-id></element-citation></ref><ref id="B109-ijms-22-03289"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lii</surname><given-names>C.K.</given-names></name><name><surname>Chen</surname><given-names>H.W.</given-names></name><name><surname>Yun</surname><given-names>W.T.</given-names></name><name><surname>Liu</surname><given-names>K.L.</given-names></name></person-group><article-title>Suppressive effects of wild bitter gourd (<italic>Momordica charantia</italic> Linn. var. <italic>abbreviata</italic> ser.) fruit extracts on inflammatory responses in RAW264.7 macrophages</article-title><source>J. Ethnopharmacol.</source><year>2009</year><volume>122</volume><fpage>227</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2009.01.028</pub-id><pub-id pub-id-type="pmid">19330915</pub-id></element-citation></ref><ref id="B110-ijms-22-03289"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y.L.</given-names></name><name><surname>Liu</surname><given-names>Y.H.</given-names></name><name><surname>Chyuan</surname><given-names>J.H.</given-names></name><name><surname>Cheng</surname><given-names>K.T.</given-names></name><name><surname>Liang</surname><given-names>W.L.</given-names></name></person-group><article-title>Antioxidant activities of different wild bitter gourd (<italic>Momordica charantia</italic> L. var</article-title><source>abbreviata Seringe) cultivars. Bot. Stud.</source><year>2012</year><volume>53</volume><fpage>207</fpage><lpage>214</lpage></element-citation></ref><ref id="B111-ijms-22-03289"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rawat</surname><given-names>R.</given-names></name><name><surname>Yu</surname><given-names>X.H.</given-names></name><name><surname>Sweet</surname><given-names>M.</given-names></name><name><surname>Shanklin</surname><given-names>J.</given-names></name></person-group><article-title>Conjugated fatty acid synthesis: Residues 111 and 115 influence product partitioning of <italic>Momordica charantia</italic> conjugase</article-title><source>J. Biol. Chem.</source><year>2012</year><volume>287</volume><fpage>16230</fpage><lpage>16237</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.325316</pub-id><pub-id pub-id-type="pmid">22451660</pub-id></element-citation></ref><ref id="B112-ijms-22-03289"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuang</surname><given-names>C.Y.</given-names></name><name><surname>Hsu</surname><given-names>C.</given-names></name><name><surname>Chao</surname><given-names>C.Y.</given-names></name><name><surname>Wein</surname><given-names>Y.S.</given-names></name><name><surname>Kuo</surname><given-names>Y.H.</given-names></name><name><surname>Huang</surname><given-names>C.J.</given-names></name></person-group><article-title>Fractionation and identification of 9c, 11t, 13t-conjugated linolenic acid as an activator of PPARalpha in bitter gourd (<italic>Momordica charantia</italic> L.)</article-title><source>J. Biomed. Sci.</source><year>2006</year><volume>13</volume><fpage>763</fpage><lpage>772</lpage><pub-id pub-id-type="doi">10.1007/s11373-006-9109-3</pub-id><pub-id pub-id-type="pmid">16955349</pub-id></element-citation></ref><ref id="B113-ijms-22-03289"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Colby</surname><given-names>J.K.</given-names></name><name><surname>Zuo</surname><given-names>X.</given-names></name><name><surname>Jaoude</surname><given-names>J.</given-names></name><name><surname>Wei</surname><given-names>D.</given-names></name><name><surname>Shureiqi</surname><given-names>I.</given-names></name></person-group><article-title>The role of PPAR-&#x003b4; in metabolism, inflammation, and cancer: Many characters of a critical transcription factor</article-title><source>Int. J. Mol. Sci.</source><year>2018</year><volume>19</volume><elocation-id>3339</elocation-id><pub-id pub-id-type="doi">10.3390/ijms19113339</pub-id></element-citation></ref><ref id="B114-ijms-22-03289"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Queiroz</surname><given-names>M.P.</given-names></name><name><surname>Lima MD</surname><given-names>S.</given-names></name><name><surname>Barbosa</surname><given-names>M.Q.</given-names></name><name><surname>de Melo MF</surname><given-names>F.T.</given-names></name><name><surname>Bertozzo CC</surname><given-names>M.S.</given-names></name><name><surname>de Oliveira ME</surname><given-names>G.</given-names></name><name><surname>Bessa RJ</surname><given-names>B.</given-names></name><name><surname>Alves SP</surname><given-names>A.</given-names></name><name><surname>Souza MI</surname><given-names>A.</given-names></name><name><surname>Queiroga RC</surname><given-names>R.D.</given-names></name><etal/></person-group><article-title>Effect of conjugated linoleic acid on memory and reflex maturation in rats treated during early life</article-title><source>Front. Neurosci.</source><year>2019</year><volume>13</volume><fpage>370</fpage><pub-id pub-id-type="doi">10.3389/fnins.2019.00370</pub-id><?supplied-pmid 31068778?><pub-id pub-id-type="pmid">31068778</pub-id></element-citation></ref><ref id="B115-ijms-22-03289"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fa</surname><given-names>M.</given-names></name><name><surname>Diana</surname><given-names>A.</given-names></name><name><surname>Carta</surname><given-names>G.</given-names></name><name><surname>Cordeddu</surname><given-names>L.</given-names></name><name><surname>Melis</surname><given-names>M.P.</given-names></name><name><surname>Murru</surname><given-names>E.</given-names></name><name><surname>Sogos</surname><given-names>V.</given-names></name><name><surname>Banni</surname><given-names>S.</given-names></name></person-group><article-title>Incorporation and metabolism of c9,t11 and t10,c12 conjugated linoleic acid (CLA) isomers in rat brain</article-title><source>Biochim. Biophys. Acta</source><year>2005</year><volume>1736</volume><fpage>61</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2005.06.010</pub-id><pub-id pub-id-type="pmid">16055372</pub-id></element-citation></ref><ref id="B116-ijms-22-03289"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guest</surname><given-names>J.</given-names></name><name><surname>Garg</surname><given-names>M.</given-names></name><name><surname>Bilgin</surname><given-names>A.</given-names></name><name><surname>Grant</surname><given-names>R.</given-names></name></person-group><article-title>Relationship between central and peripheral fatty acids in humans</article-title><source>Lipids Health Dis.</source><year>2013</year><volume>12</volume><fpage>79</fpage><pub-id pub-id-type="doi">10.1186/1476-511X-12-79</pub-id><pub-id pub-id-type="pmid">23710642</pub-id></element-citation></ref><ref id="B117-ijms-22-03289"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cappa</surname><given-names>M.</given-names></name><name><surname>Bizzarri</surname><given-names>C.</given-names></name><name><surname>Petroni</surname><given-names>A.</given-names></name><name><surname>Carta</surname><given-names>G.</given-names></name><name><surname>Cordeddu</surname><given-names>L.</given-names></name><name><surname>Valeriani</surname><given-names>M.</given-names></name><name><surname>Vollono</surname><given-names>C.</given-names></name><name><surname>De</surname><given-names>P.L.</given-names></name><name><surname>Blasevich</surname><given-names>M.</given-names></name><name><surname>Banni</surname><given-names>S.</given-names></name></person-group><article-title>A mixture of oleic, erucic and conjugated linoleic acids modulates cerebrospinal fluid inflammatory markers and improve somatosensorial evoked potential in X-linked adrenoleukodystrophy female carriers</article-title><source>J. Inherit. Metab. Dis.</source><year>2012</year><volume>35</volume><fpage>899</fpage><lpage>907</lpage><pub-id pub-id-type="doi">10.1007/s10545-011-9432-3</pub-id><pub-id pub-id-type="pmid">22189598</pub-id></element-citation></ref><ref id="B118-ijms-22-03289"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanase</surname><given-names>C.</given-names></name><name><surname>Co&#x00219;arc&#x00103;</surname><given-names>S.</given-names></name><name><surname>Muntean</surname><given-names>D.L.</given-names></name></person-group><article-title>A critical review of phenolic compounds extracted from the bark of woody vascular plants and their potential biological activity</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>1182</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24061182</pub-id></element-citation></ref><ref id="B119-ijms-22-03289"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poulose</surname><given-names>S.M.</given-names></name><name><surname>Miller</surname><given-names>M.G.</given-names></name><name><surname>Scott</surname><given-names>T.</given-names></name><name><surname>Shukitt-Hale</surname><given-names>B.</given-names></name></person-group><article-title>Nutritional factors affecting adult neurogenesis and cognitive function</article-title><source>Adv. Nutr.</source><year>2017</year><volume>8</volume><fpage>804</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.3945/an.117.016261</pub-id><?supplied-pmid 29141966?><pub-id pub-id-type="pmid">29141966</pub-id></element-citation></ref><ref id="B120-ijms-22-03289"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalogeropoulos</surname><given-names>N.</given-names></name><name><surname>Yanni</surname><given-names>A.E.</given-names></name><name><surname>Koutrotsios</surname><given-names>G.</given-names></name><name><surname>Aloupi</surname><given-names>M.</given-names></name></person-group><article-title>Bioactive microconstituents and antioxidant properties of wild edible mushrooms from the island of Lesvos, Greece</article-title><source>Food Chem. Toxicol.</source><year>2013</year><volume>55</volume><fpage>378</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2013.01.010</pub-id><?supplied-pmid 23354393?><pub-id pub-id-type="pmid">23354393</pub-id></element-citation></ref><ref id="B121-ijms-22-03289"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Hu</surname><given-names>Y.S.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Q.Z.</given-names></name><name><surname>Li</surname><given-names>N.N.</given-names></name><name><surname>Wu</surname><given-names>C.Q.</given-names></name><name><surname>Yu</surname><given-names>H.X.</given-names></name><name><surname>Guo</surname><given-names>Q.C.</given-names></name></person-group><article-title>Protective effect of tetraethyl pyrazine against focal cerebral ischemia/reperfusion injury in rats: Therapeutic time window and its mechanism</article-title><source>Thromb. Res.</source><year>2009</year><volume>123</volume><fpage>727</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1016/j.thromres.2008.11.004</pub-id><pub-id pub-id-type="pmid">19128823</pub-id></element-citation></ref><ref id="B122-ijms-22-03289"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daily</surname><given-names>J.W.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Park</surname><given-names>S.</given-names></name></person-group><article-title>Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: A systematic review and meta-analysis of randomized clinical trials</article-title><source>J. Med. Food</source><year>2016</year><volume>19</volume><fpage>717</fpage><lpage>729</lpage><pub-id pub-id-type="doi">10.1089/jmf.2016.3705</pub-id><?supplied-pmid 27533649?><pub-id pub-id-type="pmid">27533649</pub-id></element-citation></ref><ref id="B123-ijms-22-03289"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Clifton</surname><given-names>P.</given-names></name></person-group><article-title>Curcumin, cardiometabolic health and dementia</article-title><source>Int. J. Environ. Res. Public Health</source><year>2018</year><volume>15</volume><elocation-id>2093</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph15102093</pub-id><?supplied-pmid 30250013?><pub-id pub-id-type="pmid">30250013</pub-id></element-citation></ref><ref id="B124-ijms-22-03289"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Kaur</surname><given-names>M.</given-names></name><name><surname>Katnoria</surname><given-names>J.K.</given-names></name><name><surname>Nagpal</surname><given-names>A.K.</given-names></name></person-group><article-title>Polyphenols in food: Cancer prevention and apoptosis induction</article-title><source>Curr. Med. Chem.</source><year>2018</year><volume>25</volume><fpage>4740</fpage><lpage>4757</lpage><pub-id pub-id-type="doi">10.2174/0929867324666171006144208</pub-id><pub-id pub-id-type="pmid">28990504</pub-id></element-citation></ref><ref id="B125-ijms-22-03289"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menon</surname><given-names>V.P.</given-names></name><name><surname>Sudheer</surname><given-names>A.R.</given-names></name></person-group><article-title>Antioxidant and anti-inflammatory properties of curcumin</article-title><source>Adv. Exp. Med. Biol.</source><year>2007</year><volume>595</volume><fpage>105</fpage><lpage>125</lpage><?supplied-pmid 17569207?><pub-id pub-id-type="pmid">17569207</pub-id></element-citation></ref><ref id="B126-ijms-22-03289"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anuradha</surname><given-names>B.R.</given-names></name><name><surname>Bai</surname><given-names>Y.D.</given-names></name><name><surname>Sailaja</surname><given-names>S.</given-names></name><name><surname>Sudhakar</surname><given-names>J.</given-names></name><name><surname>Priyanka</surname><given-names>M.</given-names></name><name><surname>Deepika</surname><given-names>V.</given-names></name></person-group><article-title>Evaluation of anti-inflammatory effects of curcumin gel as an adjunct to scaling and root planing: A clinical study</article-title><source>J. Int. Oral Health</source><year>2015</year><volume>7</volume><fpage>90</fpage><lpage>93</lpage><?supplied-pmid 26229378?><pub-id pub-id-type="pmid">26229378</pub-id></element-citation></ref><ref id="B127-ijms-22-03289"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shishodia</surname><given-names>S.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Curcumin: Getting back to the roots</article-title><source>Ann. N. Y. Acad. Sci.</source><year>2005</year><volume>1056</volume><fpage>206</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1196/annals.1352.010</pub-id><pub-id pub-id-type="pmid">16387689</pub-id></element-citation></ref><ref id="B128-ijms-22-03289"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moran</surname><given-names>J.M.</given-names></name><name><surname>Roncero-Martin</surname><given-names>R.</given-names></name><name><surname>Rodriguez-Velasco</surname><given-names>F.J.</given-names></name><name><surname>Calderon-Garcia</surname><given-names>J.F.</given-names></name><name><surname>Rey-Sanchez</surname><given-names>P.</given-names></name><name><surname>Vera</surname><given-names>V.</given-names></name><name><surname>Canal-Macias</surname><given-names>M.L.</given-names></name><name><surname>Pedrera-Zamorano</surname><given-names>J.D.</given-names></name></person-group><article-title>Effects of curcumin on the proliferation and mineralization of human osteoblast-like cells: Implications of nitric oxide</article-title><source>Int. J. Mol. Sci.</source><year>2012</year><volume>13</volume><fpage>16104</fpage><lpage>16118</lpage><pub-id pub-id-type="doi">10.3390/ijms131216104</pub-id><pub-id pub-id-type="pmid">23443113</pub-id></element-citation></ref><ref id="B129-ijms-22-03289"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>M.L.</given-names></name><name><surname>Chacko</surname><given-names>K.M.</given-names></name><name><surname>Kuruvilla</surname><given-names>B.T.</given-names></name></person-group><article-title>Systematic and comprehensive investigation of the toxicity of curcuminoid-essential oil complex: A bioavailable turmeric formulation</article-title><source>Mol. Med. Rep.</source><year>2016</year><volume>13</volume><fpage>592</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.3892/mmr.2015.4579</pub-id><pub-id pub-id-type="pmid">26648561</pub-id></element-citation></ref><ref id="B130-ijms-22-03289"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurenka</surname><given-names>J.S.</given-names></name></person-group><article-title>Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research</article-title><source>Altern. Med. Rev.</source><year>2009</year><volume>14</volume><fpage>141</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">19594223</pub-id></element-citation></ref><ref id="B131-ijms-22-03289"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bengmark</surname><given-names>S.</given-names></name><name><surname>Mesa</surname><given-names>M.D.</given-names></name><name><surname>Gil</surname><given-names>A.</given-names></name></person-group><article-title>Plant-derived health: The effects of turmeric and curcuminoids</article-title><source>Nutr. Hosp.</source><year>2009</year><volume>24</volume><fpage>273</fpage><lpage>281</lpage><pub-id pub-id-type="pmid">19721899</pub-id></element-citation></ref><ref id="B132-ijms-22-03289"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taei-Almanghadim</surname><given-names>K.</given-names></name><name><surname>Farshbaf-Khalili</surname><given-names>A.</given-names></name><name><surname>Ostadrahimi</surname><given-names>A.R.</given-names></name><name><surname>Shaseb</surname><given-names>E.</given-names></name><name><surname>Mirghafourvand</surname><given-names>M.</given-names></name></person-group><article-title>The effect of oral capsule of curcumin and vitamin E on the hot flashes and anxiety in postmenopausal women: A triple blind randomised controlled trial</article-title><source>Complement Ther. Med.</source><year>2020</year><volume>48</volume><fpage>102267</fpage><pub-id pub-id-type="doi">10.1016/j.ctim.2019.102267</pub-id><pub-id pub-id-type="pmid">31987231</pub-id></element-citation></ref><ref id="B133-ijms-22-03289"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewlings</surname><given-names>S.J.</given-names></name><name><surname>Kalman</surname><given-names>D.S.</given-names></name></person-group><article-title>Curcumin: A review of its effects on human health</article-title><source>Foods</source><year>2017</year><volume>6</volume><elocation-id>92</elocation-id><pub-id pub-id-type="doi">10.3390/foods6100092</pub-id><?supplied-pmid 29065496?><pub-id pub-id-type="pmid">29065496</pub-id></element-citation></ref><ref id="B134-ijms-22-03289"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>W.M.</given-names></name><name><surname>Hunsaker</surname><given-names>L.A.</given-names></name><name><surname>Gonzales</surname><given-names>A.M.</given-names></name><name><surname>Heynekamp</surname><given-names>J.J.</given-names></name><name><surname>Orlando</surname><given-names>R.A.</given-names></name><name><surname>Deck</surname><given-names>L.M.</given-names></name><name><surname>Vander Jagt</surname><given-names>D.L.</given-names></name></person-group><article-title>TPA-induced up-regulation of activator protein-1 can be inhibited or enhanced by analogs of the natural product curcumin</article-title><source>Biochem. Pharmacol.</source><year>2006</year><volume>72</volume><fpage>928</fpage><lpage>940</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2006.07.007</pub-id><?supplied-pmid 16934760?><pub-id pub-id-type="pmid">16934760</pub-id></element-citation></ref><ref id="B135-ijms-22-03289"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>M.S.</given-names></name><name><surname>Lee</surname><given-names>Y.H.</given-names></name><name><surname>Chiu</surname><given-names>W.T.</given-names></name><name><surname>Hung</surname><given-names>K.S.</given-names></name></person-group><article-title>Curcumin provides neuroprotection after spinal cord injury</article-title><source>J. Surg. Res.</source><year>2011</year><volume>166</volume><fpage>280</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2009.07.001</pub-id><?supplied-pmid 20018302?><pub-id pub-id-type="pmid">20018302</pub-id></element-citation></ref><ref id="B136-ijms-22-03289"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>M.S.</given-names></name><name><surname>Sun</surname><given-names>Y.Y.</given-names></name><name><surname>Chiu</surname><given-names>W.T.</given-names></name><name><surname>Hung</surname><given-names>C.C.</given-names></name><name><surname>Chang</surname><given-names>C.Y.</given-names></name><name><surname>Shie</surname><given-names>F.S.</given-names></name><name><surname>Tsai</surname><given-names>S.H.</given-names></name><name><surname>Lin</surname><given-names>J.W.</given-names></name><name><surname>Hung</surname><given-names>K.S.</given-names></name><name><surname>Lee</surname><given-names>Y.H.</given-names></name></person-group><article-title>Curcumin attenuates the expression and secretion of RANTES after spinal cord injury in vivo and lipopolysaccharide-induced astrocyte reactivation in vitro</article-title><source>J. Neurotrauma</source><year>2011</year><volume>28</volume><fpage>1259</fpage><lpage>1269</lpage><pub-id pub-id-type="doi">10.1089/neu.2011.1768</pub-id><pub-id pub-id-type="pmid">21529317</pub-id></element-citation></ref><ref id="B137-ijms-22-03289"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nery-Flores</surname><given-names>S.D.</given-names></name><name><surname>Ram&#x000ed;rez-Herrera</surname><given-names>M.A.</given-names></name><name><surname>Mendoza- Maga&#x000f1;a</surname><given-names>M.L.</given-names></name><name><surname>Romero-Prado MM</surname><given-names>J.</given-names></name><name><surname>Ram&#x000ed;rez-V&#x000e1;zquez</surname><given-names>J.J.</given-names></name><name><surname>Ba&#x000f1;uelos-Pineda</surname><given-names>J.</given-names></name><name><surname>Espinoza-Guti&#x000e9;rrez</surname><given-names>H.A.</given-names></name><name><surname>Ram&#x000ed;rez-Mendoza</surname><given-names>A.A.</given-names></name><name><surname>Tostado</surname><given-names>M.C.</given-names></name></person-group><article-title>Dietary curcumin prevented astrocytosis, microgliosis, and apoptosis caused by acute and chronic exposure to ozone</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>2839</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24152839</pub-id></element-citation></ref><ref id="B138-ijms-22-03289"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zong</surname><given-names>W.X.</given-names></name><name><surname>Lindsten</surname><given-names>T.</given-names></name><name><surname>Ross</surname><given-names>A.J.</given-names></name><name><surname>MacGregor</surname><given-names>G.R.</given-names></name><name><surname>Thompson</surname><given-names>C.B.</given-names></name></person-group><article-title>BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak</article-title><source>Genes Dev.</source><year>2001</year><volume>15</volume><fpage>1481</fpage><lpage>1486</lpage><pub-id pub-id-type="doi">10.1101/gad.897601</pub-id><?supplied-pmid 11410528?><pub-id pub-id-type="pmid">11410528</pub-id></element-citation></ref><ref id="B139-ijms-22-03289"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Priyadarsini</surname><given-names>K.I.</given-names></name></person-group><article-title>Free radical reactions of curcumin in membrane models</article-title><source>Free Radic. Biol. Med.</source><year>1997</year><volume>23</volume><fpage>838</fpage><lpage>843</lpage><pub-id pub-id-type="doi">10.1016/S0891-5849(97)00026-9</pub-id><pub-id pub-id-type="pmid">9378362</pub-id></element-citation></ref><ref id="B140-ijms-22-03289"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Sun</surname><given-names>A.Y.</given-names></name><name><surname>Simonyi</surname><given-names>A.</given-names></name><name><surname>Jensen</surname><given-names>M.D.</given-names></name><name><surname>Shelat</surname><given-names>P.B.</given-names></name><name><surname>Rottinghaus</surname><given-names>G.E.</given-names></name><name><surname>MacDonald</surname><given-names>R.S.</given-names></name><name><surname>Miller</surname><given-names>D.K.</given-names></name><name><surname>Lubahn</surname><given-names>D.E.</given-names></name><name><surname>Weisman</surname><given-names>G.A.</given-names></name><etal/></person-group><article-title>Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits</article-title><source>J. Neurosci. Res.</source><year>2005</year><volume>82</volume><fpage>138</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1002/jnr.20610</pub-id><pub-id pub-id-type="pmid">16075466</pub-id></element-citation></ref><ref id="B141-ijms-22-03289"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Alloza</surname><given-names>M.</given-names></name><name><surname>Borrelli</surname><given-names>L.A.</given-names></name><name><surname>Rozkalne</surname><given-names>A.</given-names></name><name><surname>Hyman</surname><given-names>B.T.</given-names></name><name><surname>Bacskai</surname><given-names>B.J.</given-names></name></person-group><article-title>Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model</article-title><source>J. Neurochem.</source><year>2007</year><volume>102</volume><fpage>1095</fpage><lpage>1104</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2007.04613.x</pub-id><?supplied-pmid 17472706?><pub-id pub-id-type="pmid">17472706</pub-id></element-citation></ref><ref id="B142-ijms-22-03289"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kowluru</surname><given-names>R.A.</given-names></name><name><surname>Kanwar</surname><given-names>M.</given-names></name></person-group><article-title>Effects of curcumin on retinal oxidative stress and inflammation in diabetes</article-title><source>Nutr. Metab.</source><year>2007</year><volume>4</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.1186/1743-7075-4-8</pub-id><?supplied-pmid 17437639?><pub-id pub-id-type="pmid">17437639</pub-id></element-citation></ref><ref id="B143-ijms-22-03289"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.F.</given-names></name><name><surname>Gu</surname><given-names>Y.T.</given-names></name><name><surname>Qin</surname><given-names>G.H.</given-names></name><name><surname>Zhong</surname><given-names>L.</given-names></name><name><surname>Meng</surname><given-names>Y.N.</given-names></name></person-group><article-title>Curcumin ameliorates the permeability of the blood-brain barrier during hypoxia by upregulating heme oxygenase-1 expression in brain microvascular endothelial cells</article-title><source>J. Mol. Neurosci.</source><year>2013</year><volume>51</volume><fpage>344</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1007/s12031-013-9989-4</pub-id><?supplied-pmid 23494637?><pub-id pub-id-type="pmid">23494637</pub-id></element-citation></ref><ref id="B144-ijms-22-03289"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>D.S.</given-names></name><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Mei</surname><given-names>X.F.</given-names></name><name><surname>Wang</surname><given-names>Y.F.</given-names></name><name><surname>Fan</surname><given-names>Z.K.</given-names></name><name><surname>Wang</surname><given-names>Y.S.</given-names></name><name><surname>Lv</surname><given-names>G.</given-names></name></person-group><article-title>Curcumin improves the integrity of blood-spinal cord barrier after compressive spinal cord injury in rats</article-title><source>J. Neurol. Sci.</source><year>2014</year><volume>346</volume><fpage>51</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.jns.2014.07.056</pub-id><pub-id pub-id-type="pmid">25129208</pub-id></element-citation></ref><ref id="B145-ijms-22-03289"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanivarapu</surname><given-names>R.</given-names></name><name><surname>Vallabhaneni</surname><given-names>V.</given-names></name><name><surname>Verma</surname><given-names>V.</given-names></name></person-group><article-title>The potential of curcumin in treatment of spinal cord injury</article-title><source>Neurol. Res. Int.</source><year>2016</year><volume>2016</volume><fpage>9468193</fpage><pub-id pub-id-type="doi">10.1155/2016/9468193</pub-id><?supplied-pmid 27298735?><pub-id pub-id-type="pmid">27298735</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="ijms-22-03289-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Diagram of CNS pathology&#x02013;CISD2-NF&#x003ba;B axis. CDGSH iron-sulfur domain 2 (CISD2) expression can be reduced under circumstances of CNS injuries and diseases, such as aging, neurodegenerative disease, and neurotrauma. CISD2 serves as NF&#x003ba;B antagonist. As such, injury-induced decline in CISD2 leads to enhanced NF&#x003ba;B and thereby NF&#x003ba;B-provokes neuroinflammation and mitochondrial dysfunction. CISD2-elevating strategies help to mitigate NF&#x003ba;B-provoked inflammation and mitochondrial dysfunction. Curcumin from <italic>Curcuma longa</italic> L. and &#x003b1;-ESA from <italic>Momordica charantia L. var. abbreviata Ser.</italic> (wild bitter melon) exert anti-inflammatory and CISD2-preservation effects. Any novel plant extracts able to exhibit neuromodulatory effects on this axis of CNS pathology&#x02013;CISD2-NF&#x003ba;B can be considered to be applied in CNS injuries and diseases.</p></caption><graphic xlink:href="ijms-22-03289-g001"/></fig><fig id="ijms-22-03289-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>&#x003b1;-ESA, a conjugated linolenic acid (CLNA) isomer, exerts CISD2-elevating effect. Polyunsaturated fatty acids (PUFAs) are mainly divided into two categories, &#x003c9;-3 and &#x003c9;-6. Linoleic acid and &#x003b1;-linolenic acid represent the most fatty acids in the &#x003c9;-6 and &#x003c9;-3 fatty acids, respectively. By removing the methylene group (represented as a circle) between double bonds in linoleic acid (left sided chemical structure) and &#x003b1;-linolenic acid (right sided chemical structure), conjugated linoleic acid (CLA) and CLNA isomers are derived. As a phytochemical of wild bitter melon (WBM), &#x003b1;-ESA is a CLNA isomer, which can elevate expression levels of CISD2 (indicated as remark 1). CISD2 serves as a PPAR-&#x003b2; regulator at upstream level. &#x003b1;-ESA can be converted to CLA (indicated as remark 2). CLA has been demonstrated to function as PPAR-&#x003b2; ligand (indicated as remark 3). As a result, &#x003b1;-ESA-driven CISD2 activation induces PPAR-&#x003b2; upregulation, causing the inhibition of I&#x003ba;B degradation and NF-&#x003ba;B activation.</p></caption><graphic xlink:href="ijms-22-03289-g002"/></fig><fig id="ijms-22-03289-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Chemical structure of curcuminoids: curcumin, demethoxycurcumin, and bisdemethoxycurcumin.</p></caption><graphic xlink:href="ijms-22-03289-g003"/></fig></floats-group></article>